Refine
Year of publication
- 2024 (9)
- 2023 (13)
- 2022 (72)
- 2021 (73)
- 2020 (85)
- 2019 (89)
- 2018 (92)
- 2017 (84)
- 2016 (84)
- 2015 (75)
- 2014 (58)
- 2013 (40)
- 2012 (61)
- 2011 (52)
- 2010 (28)
- 2009 (39)
- 2008 (13)
- 2007 (14)
- 2006 (32)
- 2005 (42)
- 2004 (39)
- 2003 (31)
- 2002 (17)
- 2001 (25)
- 2000 (27)
- 1999 (21)
- 1998 (13)
- 1997 (14)
- 1996 (5)
- 1995 (18)
- 1994 (17)
- 1993 (4)
- 1992 (1)
- 1991 (2)
- 1989 (1)
- 1988 (1)
- 1987 (1)
- 1982 (1)
Document Type
- Article (790)
- Doctoral Thesis (280)
- Postprint (106)
- Conference Proceeding (38)
- Review (34)
- Other (32)
- Monograph/Edited Volume (9)
- Habilitation Thesis (5)
- Preprint (2)
- Master's Thesis (1)
Keywords
- inflammation (24)
- obesity (19)
- oxidative stress (15)
- insulin (14)
- insulin resistance (14)
- type 2 diabetes (14)
- Biomarker (13)
- LC-MS/MS (13)
- cancer (12)
- carotenoids (12)
- Adipositas (10)
- FGF21 (10)
- selenium (10)
- sphingolipids (10)
- Insulin resistance (9)
- acid sphingomyelinase (9)
- ceramide (9)
- cytokines (9)
- metabolic syndrome (9)
- α-amylase/trypsin inhibitors (9)
- Caenorhabditis elegans (8)
- Manganese (8)
- Selen (8)
- protein (8)
- Oxidative stress (7)
- adipose tissue (7)
- mass spectrometry (7)
- metabolism (7)
- pregnancy (7)
- retinol (7)
- vitamin A (7)
- C. elegans (6)
- Geschmack (6)
- Mitochondria (6)
- NASH (6)
- Obesity (6)
- Pregnancy (6)
- Prunus avium L. (6)
- SDS-PAGE (6)
- Solanaceae (6)
- Vitamin A (6)
- aging (6)
- cholesterol (6)
- diabetes (6)
- diet (6)
- disease (6)
- epigenetics (6)
- polyphenols (6)
- probiotics (6)
- retinol-binding protein 4 (6)
- taste (6)
- zinc (6)
- Aging (5)
- Arsenolipids (5)
- DNA damage (5)
- DNA methylation (5)
- Dexamethasone (5)
- Energiestoffwechsel (5)
- Entzündung (5)
- Epigenetics (5)
- Fetal programming (5)
- HPLC (5)
- Inflammation (5)
- Insulin (5)
- LC–MS/MS (5)
- NAFLD (5)
- Sphingolipids (5)
- Sphingosine 1-phosphate (5)
- Type 2 diabetes (5)
- adiponectin (5)
- biomarker (5)
- cardiovascular disease (5)
- coffee by-products (5)
- genes (5)
- linagliptin (5)
- liver (5)
- manganese (5)
- mitochondria (5)
- plasma (5)
- protein modification (5)
- type 2 diabetes mellitus (5)
- wheat (5)
- Adipose tissue (4)
- Arsenic-containing fatty acids (4)
- Arsenic-containing hydrocarbons (4)
- C-reactive protein (4)
- Cardiovascular diseases (4)
- Carotenoids (4)
- Diabetes (4)
- Emulsion (4)
- Endothelin (4)
- Flower buds (4)
- GDF15 (4)
- Hypertension (4)
- Mass spectrometry (4)
- Metabolisches Syndrom (4)
- PUFA (4)
- Placenta (4)
- SDS PAGE (4)
- Sphingosine-1-phosphate (4)
- Typ-2-Diabetes (4)
- Vitamin E (4)
- Zinc (4)
- adipogenesis (4)
- brain (4)
- cell-based assay (4)
- cells (4)
- chronic kidney disease (4)
- copper (4)
- database (4)
- electrochemistry (4)
- epidemiology (4)
- glutathione peroxidase (4)
- gut microbiota (4)
- lipid metabolism (4)
- lutein (4)
- macrophages (4)
- malnutrition (4)
- metabolomics (4)
- micronutrients (4)
- neurodegeneration (4)
- neurotoxicity (4)
- non-alcoholic fatty liver disease (4)
- proteinuria (4)
- refinement (4)
- resistin (4)
- transcriptomics (4)
- weight loss (4)
- Abscisic acid (3)
- Acid sphingomyelinase (3)
- African indigenous vegetables (3)
- Alterung (3)
- Arabica coffee beans (3)
- BMI (3)
- Bilophila wadsworthia (3)
- Bioavailability (3)
- Bittergeschmack (3)
- Boron exposure (3)
- Diabetic nephropathy (3)
- Doehlert design (3)
- Dormancy (3)
- Drug delivery (3)
- Ernährung (3)
- Fettstoffwechsel (3)
- GCN2 (3)
- Glucagon (3)
- Glucosinolates (3)
- Hepatocytes (3)
- Insulinresistenz (3)
- Kidney (3)
- MALDI-TOF-MS (3)
- Mendelian randomization (3)
- Meta-analysis (3)
- Methylmercury (3)
- Mitochondrien (3)
- NZO (3)
- Neurotoxicity (3)
- Nrf2 (3)
- Nutrition (3)
- Proteom (3)
- Selenium (3)
- Skeletal muscle (3)
- Sphingosine kinase (3)
- Stability (3)
- TEM (3)
- Toxicity (3)
- Verhalten (3)
- acid ceramidase (3)
- activated carbon (3)
- adiposity (3)
- age (3)
- ageing (3)
- antioxidants (3)
- beta-cell (3)
- bioavailability (3)
- biofortification (3)
- bitter taste (3)
- chronic diseases (3)
- coffee processing (3)
- colorectal cancer (3)
- diabetic nephropathy (3)
- differentiation (3)
- elevated plus-maze (3)
- energy metabolism (3)
- fatty acid metabolism (3)
- fatty acids (3)
- fibrosis (3)
- food choice (3)
- gallbladder cancer (3)
- glucocorticoid receptor (3)
- glucose (3)
- goblet cells (3)
- heart (3)
- high-sodium (3)
- homeostasis (3)
- iCheck (3)
- infection (3)
- kidney transplantation (3)
- lifestyle (3)
- lipidomics (3)
- liver metabolism (3)
- mitochondrial dysfunction (3)
- model (3)
- mortality (3)
- neurodegenerative diseases (3)
- nutrition (3)
- omega-3 fatty acids (3)
- open-field (3)
- overweight (3)
- p53 (3)
- plant volatiles (3)
- polymorphism (3)
- post-natal (3)
- pre-natal (3)
- prevention (3)
- prostaglandin E2 (3)
- proteasome (3)
- protein restriction (3)
- proteome (3)
- proteostasis (3)
- red meat (3)
- redox state (3)
- saliva (3)
- sample preparation (3)
- sarcopenia (3)
- selenoprotein P (3)
- sphingomyelin (3)
- sphingosine (3)
- sphingosine-1-phosphate (3)
- sulfotransferase (3)
- survival (3)
- tocopherols (3)
- transformation products (3)
- transthyretin (3)
- type 2 (3)
- vascular calcification (3)
- vegetables (3)
- 1-Hydroxymethylpyren (2)
- 1-aminodecylidene bis-phosphonic acid (2)
- AMD (2)
- Ageing (2)
- Akt pathway (2)
- Amino acids (2)
- Amylase (2)
- Anemia (2)
- Apoptosis (2)
- Arabica coffee (2)
- Arabidopsis (2)
- Arsenic (2)
- BMI change (2)
- Beer (2)
- Birth weight (2)
- Blood (2)
- Blood pressure (2)
- BoNT (2)
- BoNT/B uptake (2)
- Boric acid (2)
- Botulinum neurotoxin (2)
- COVID 19 (2)
- CRISPR editing validation (2)
- CVD (2)
- Caco-2 (2)
- Caco-2 intestinal barrier model (2)
- Caco-2/HT-29-MTX-model (2)
- Caenorhabitis elegans (2)
- Camellia sinensis (2)
- Carotenoid (2)
- Carotinoide (2)
- Cattle (2)
- Ceramide (2)
- Ceramides (2)
- Cereals (2)
- Christentum (2)
- Chrysopidae (2)
- Circadian rhythm (2)
- Clinical (2)
- Cohort studies (2)
- Copper (2)
- Cow-side assay (2)
- Curcumin (2)
- Cytotoxicity (2)
- DNA adducts (2)
- DNA damage response (2)
- DNA repair (2)
- DPP-4 inhibitors (2)
- Development (2)
- Differenzierung (2)
- Donors (2)
- Dopamine (2)
- E-2 (2)
- ET-1 (2)
- Endothelial cells (2)
- Endothelin-1 (2)
- Energy metabolism (2)
- Epidemiologie (2)
- Ernährungsfaktoren (2)
- Ernährungsgewohnheit (2)
- Ethanol (2)
- FTY720 (2)
- Ferritin (2)
- Fettgewebe (2)
- Fettsäuren (2)
- Flavonoid (2)
- Fluorescence (2)
- Food labeling (2)
- Foxp3 (2)
- GI-GPx (2)
- GPx activity (2)
- Genotoxicity (2)
- Genregulation (2)
- Gestational diabetes (2)
- Gestational diabetes mellitus (2)
- Global DNA methylation (2)
- Glucose homeostasis (2)
- Glutathionperoxidase (2)
- HEK293 (2)
- HRMS (2)
- Hemoglobin (2)
- HepG2 (2)
- Hypermethylation (2)
- IGF-1 (2)
- IL-8 transcription (2)
- In vitro blood-brain barrier model (2)
- Inflammatory bowel disease (2)
- Insulin secretion (2)
- Intuitives Essen (2)
- Iron deficiency anemia (2)
- Islam (2)
- Isoflavone (2)
- Judentum (2)
- Jurkat cells (2)
- Kaffee (2)
- Körperzusammensetzung (2)
- LC-MRM-MS (2)
- LC/HRMS (2)
- Labile zinc (2)
- Lebensstil (2)
- Leber (2)
- Linagliptin (2)
- Lipid metabolism (2)
- Lipidomics (2)
- Lymphocytes (2)
- M1/M2 differentiation (2)
- MALDI-TOF/MS (2)
- MRSA (2)
- Makrophagen (2)
- Maus (2)
- Meat (2)
- Mediterranean diet (2)
- Mercaptursäure (2)
- Mercuric mercury (2)
- Metabolomics (2)
- Method comparison (2)
- Microarray (2)
- Modified mycotoxins (2)
- Mortality (2)
- Mycotoxins (2)
- NAFLD/MAFLD (2)
- Nahrungssulfonate (2)
- Neutrophils (2)
- Nitric oxide (2)
- Nährstoffe (2)
- PTH (2)
- PXR (2)
- Pak choi (2)
- Palmitate (2)
- Parkinson disease (2)
- Pesticides (2)
- Phenole (2)
- Phenological modelling (2)
- Phenylpropanoids (2)
- Plackett–Burman design (2)
- Polymorphismus (2)
- Polyphenole (2)
- Post mortem chemistry (2)
- Prediabetes (2)
- Prevention (2)
- Prostaglandin E2 (2)
- Proteasome (2)
- Protein oxidation (2)
- Protein restriction (2)
- RBP4 (2)
- RNAseq (2)
- RRR (2)
- Rats (2)
- Redoxregulation (2)
- Religiöses Leben (2)
- Renal failure (2)
- Reticulocytes (2)
- Review (2)
- S-XRF (2)
- SCFA (2)
- SFA (2)
- SIMS techniques (2)
- Sarcopenia (2)
- Se (2)
- Selenoproteine (2)
- Skeletal muscle cells (2)
- Skin nanocarrier (2)
- Skin penetration (2)
- Small for gestational age (2)
- Smpd1 (2)
- Solanum lycopersicum (2)
- Speisegebot (2)
- Stoffwechsel (2)
- Stress response (2)
- Sulforaphan (2)
- Sulfotransferase (2)
- TAS2R (2)
- TLR signaling (2)
- Tandem mass spectrometry (2)
- Technical enzymes (2)
- Tenebrio molitor larvae (2)
- Thiomersal (2)
- Thioredoxin (2)
- Tight Junction (2)
- Trace elements (2)
- Typ-2-Diabetes mellitus (2)
- VGCC (2)
- Vitamin K (2)
- Vollkorn (2)
- Whey protein (2)
- Xylanase (2)
- Zinc homeostasis (2)
- accumulation (2)
- activation (2)
- acute kidney injury (2)
- adipose tissue dysregulation (2)
- aflatoxin B1 (2)
- albuminuria (2)
- alkylierte polyzyklische aromatische Kohlenwasserstoffe (2)
- all-cause mortality (2)
- angiotensin receptor blockers (2)
- animal welfare (2)
- anorexia (2)
- anthropometric measures (2)
- anti-genotoxicity (2)
- anti-inflammatory nutrition (2)
- anti-oxidant activity (2)
- anti-oxidative capacity (2)
- anxiety-like behavior (2)
- apoptosis (2)
- appetite (2)
- ascorbate (2)
- atherosclerosis (2)
- autophagy (2)
- base excision repair (incision activity) (2)
- batch process (2)
- behavior (2)
- benzylic alcohol (2)
- benzylischer Alkohol (2)
- binding (2)
- biological pest control (2)
- birth weight (2)
- bisphosphonates (2)
- bitter (2)
- bitter taste receptors (2)
- blood pressure (2)
- body weight gain (2)
- botulinum toxin (2)
- bound phenolic compounds (2)
- brain insulin signaling (2)
- c. elegans (2)
- calcination (2)
- calcium (2)
- cancer cachexia (2)
- cancer chemoprevention (2)
- cancer epidemiology (2)
- cardiovascular diseases (2)
- carotenoid (2)
- carotenoid biosynthesis (2)
- cellular bioimaging (2)
- cerami-des (2)
- ceramides (2)
- cereal meals (2)
- chaperones (2)
- chronic fatigue (2)
- chronic psychosocial stress (2)
- chronic subordinate colony housing (CSC) (2)
- chronisch-entzündliche Darmerkrankungen (2)
- circadian clock (2)
- clusterin (2)
- coenzyme-a (2)
- coffee (2)
- colon carcinogenesis (2)
- continuous process (2)
- copper-related disorders (2)
- copy number analyses (2)
- coronary heart disease (2)
- cortisol (2)
- cyclooxygenase (2)
- cysteine alkylation (2)
- cytokine (2)
- depressive-like behavior (2)
- design of experiment (2)
- determinants (2)
- diabetes mellitus (2)
- dietary patterns (2)
- dietary restriction (2)
- digestive enzymes quantification (2)
- dogs (2)
- dormancy (2)
- drug delivery (2)
- eNOS (2)
- eicosanoids (2)
- endothelin (2)
- endurance exercise (2)
- energy homeostasis (2)
- energy-metabolism (2)
- enzymology (2)
- equine (2)
- erythropoiesis (2)
- ethanol (2)
- exercise (2)
- exposome (2)
- exposome‐ wide association study (2)
- expression (2)
- extraction (2)
- fatigue reduction diet (2)
- fatty liver (2)
- feeding (2)
- fermentation (2)
- fetal origins hypothesis (2)
- fetal programming (2)
- flavonoid (2)
- flavonoids (2)
- flower buds (2)
- food frequency questionnaire (2)
- force-field (2)
- forebrain (2)
- fractionation (2)
- fruit (2)
- functional inhibitors of acid sphin-gomyelinase (2)
- gene expression (2)
- genetically modified BoNT (2)
- glomerular filtration rate (2)
- glucagon (2)
- glucose intolerance (2)
- glucosinolates (2)
- glutathione (2)
- glycaemic control (2)
- growth behavior (2)
- growth restriction (2)
- gwas (2)
- hallervorden-spatz-syndrome (2)
- halophytes (2)
- hepatic steatosis (2)
- high protein diet (2)
- homologous recombination deficiency (2)
- homology-directed repair (2)
- hsp-70 (2)
- human excised skin (2)
- hydrolysis (2)
- hypertension (2)
- immunology (2)
- in vitro intestinal model (2)
- insulin signaling (2)
- insulin-resistance (2)
- interleukin-8 (2)
- intestinal microbiota (2)
- intestinal mucins (2)
- intestinal zinc resorption (2)
- ion-exchange chromatography (2)
- keratinocytes (2)
- kidney (2)
- kupffer cells (2)
- laboratory mice (2)
- laminitis (2)
- later health (2)
- legumes (2)
- leptin (2)
- life-span (2)
- lipid peroxidation (2)
- liver fibrosis (2)
- loci (2)
- low birth weight (2)
- lung infection (2)
- lymphoma (2)
- lysosomal hydrolases (2)
- lysosome (2)
- maintenance of genomic integrity (2)
- mass index (2)
- meal timing (2)
- melatonin (2)
- membrane fusion (2)
- menadione (2)
- mercapturic acid (2)
- meta-analysis (2)
- metabolic cage (2)
- metabolic disorders (2)
- metabolic stress (2)
- metabolic syndrom (2)
- method comparison (2)
- methylmercury (2)
- mice lacking (2)
- microarray (2)
- microcomputed tomography (2)
- microvascular complications (2)
- microwave assisted digestion (2)
- middle adulthood (2)
- mitochondria homeostasis (2)
- mitochondrial function (2)
- mobility-mass spectrometry (2)
- monensin (2)
- monitoring (2)
- mouse (2)
- mucus layer (2)
- multiple-pest infestation (2)
- muscarinic acetylcholine receptor (2)
- myalgic encephalomyelitis (2)
- myocardial infarction (2)
- myopathy (2)
- n-acetyl-cysteine (2)
- nanogels (2)
- nanoparticles (2)
- nanotoxicology (2)
- native American ancestry (2)
- neurotoxins (2)
- nitric oxide (2)
- non-alcoholic fatty liver disease (NAFLD) (2)
- nonalcoholic steatohepatthis (2)
- nut allergenic proteins (2)
- nutrient transport (2)
- nutrients (2)
- nutritional characteristics (2)
- nuts (2)
- odd chain fatty acids (2)
- offspring (2)
- older persons (2)
- organic compounds adsorption (2)
- parchment (2)
- particle characterization (2)
- patterns (2)
- pea (2)
- peptide biomarkers (2)
- peptides markers (2)
- phagocytosis (2)
- phenolics (2)
- physical activity (2)
- pink1 (2)
- plasma measurements (2)
- platelets (2)
- pneumonia (2)
- poly(ADP-ribosyl)ation (2)
- polyenoic fatty acids (2)
- population-specific risk marker (2)
- prediction (2)
- proliferation (2)
- prospective study (2)
- prostaglandins (2)
- protein extraction (2)
- proteomic analysis (2)
- proteomics (2)
- provitamin A (2)
- purification (2)
- rapid test kit (2)
- rat (2)
- rat hepatocytes (2)
- redox regulation (2)
- redox-metabolites (2)
- reducing agents (2)
- relative quantification (2)
- reliability (2)
- renal disease (2)
- repetitive elements (2)
- replacement (2)
- reversed-phase chromatography (2)
- risk (2)
- rotes Fleisch (2)
- s-glutathionylation (2)
- saline agriculture (2)
- salt (2)
- secondary plant metabolites (2)
- seeds (2)
- selenite (2)
- selenoneine (2)
- selenoproteins (2)
- serine palmitoyltransferase (2)
- serum (2)
- sex (2)
- signal transduction (2)
- size (2)
- skeletal muscle (2)
- skin penetration (2)
- sorghum (2)
- soy protein (2)
- spent coffee grounds (2)
- sphingolipid de novo synthesis (2)
- sphingolipid metabolism (2)
- sphingosine kinase (2)
- stable-isotope labeling (2)
- status markers (2)
- stroke (2)
- suppress VLDL secretion (2)
- tacrolimus formulation (2)
- targeted proteomics (2)
- tetanus toxin (2)
- tight junction (2)
- tritrophic system (2)
- tryptic digestion (2)
- ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) (2)
- ungeradkettige Fettsäuren (2)
- validity (2)
- valorization (2)
- variants (2)
- veterinary drugs (2)
- vicious cycle (2)
- visfatin (2)
- voltage-dependent calcium channels (2)
- weight gain (2)
- wheat cultivars (2)
- zinc binding (2)
- (2E)-Hexadecenal (1)
- (2E)-hexadecenal (1)
- (2E)-hexadecenoic acid (1)
- (9Z)-neoxanthin (1)
- 1-Methoxy-3-indolylmethyl glucosinolate (1)
- 1-Phenylethanol (1)
- 1-hydroxy methyl pyrene (1)
- 1-hydroxymethylpyrene (1)
- 1-phosphate (1)
- 11 beta-hydroxysteroid dehydrogenase 2 (1)
- 2-Phenylethanol (1)
- 20S (1)
- 20S proteasome (1)
- 25-OH vitamin D (1)
- 2D-LC-MS/MS (1)
- 2k1c renovascular hypertension (1)
- 3,4-didehydroretinol (1)
- 3,5-Dimethoxytoluene (1)
- 3-Methylhistidin (1)
- 3-methylhistidine (1)
- 3D breast cell model (1)
- 3D tissue model (1)
- 4-HNE (1)
- 5-gliadin (1)
- 5/6 nephrectomy (1)
- 6-Shogaol (1)
- 6-shogaol (1)
- 7 macrophages (1)
- ACE I/D polymorphism (1)
- ACE inhibitors (1)
- ADPKD (1)
- AGE (1)
- AMPK (1)
- AOAC (1)
- APC (1)
- APOM protein (1)
- ARB (1)
- ARPE-19 cells (1)
- ASI-3 (1)
- Abrus precatorius (1)
- Acute coronary syndrome (1)
- Acute renal failure (1)
- Adioponectin (1)
- Adipocytes (1)
- Adipozyt (1)
- Adult height (1)
- Advanced fetal programming hypothesis (1)
- Advanced glycation end products (1)
- Advanced glycation end-products (1)
- Advanced glycation endproducts (1)
- Aflatoxin B1 (1)
- Age (1)
- Agonisteninteraktion (1)
- Akkermansia muciniphila (1)
- Akt (1)
- Akt signaling (1)
- Akt/PKB (1)
- Aktivkohle (1)
- Alcohol dependence (1)
- Aldehyddehydrogenase (1)
- Alkohol (1)
- Alkoholdehydrogenase (1)
- Alkoholkonsum (1)
- Allantoin (1)
- Allergenic food (1)
- Allicin (1)
- Alltagsbedingungen (1)
- Allyl isothiocyanate (1)
- Alpine metamorphism (1)
- Alter (1)
- Alternative to animal testing (1)
- Alternativmethoden (1)
- Alveolar epithelial cells (1)
- Amaranth (1)
- Amaranthaceae (1)
- Anaphylatoxin (1)
- Anaphylaxie (1)
- Anatomy (1)
- Angiotensin converting enzyme inhibitor (1)
- Animal (1)
- Ankle-brachial index (1)
- Anorexia (1)
- Antibacterial (1)
- Antibeschlag-Additive (1)
- Antibiotics (1)
- Antibiotikaresistenz (1)
- Antifouling (1)
- Antimicrobial drugs (1)
- Antioxidant capacity (1)
- Antioxidants (1)
- Anxiety (1)
- Anxiety Sensitivity Index (1)
- Aortic valve (1)
- Apgar score (1)
- Apple polyphenoloxidase (1)
- Arabica Kaffeebohnen (1)
- Arbuscularmycorrhizal fungi (1)
- Arsenic speciation (1)
- Arsenite (1)
- Arsenolipid (1)
- Arsenosugar (1)
- Aryl-hydrocarbon receptor (1)
- Asian subjects (1)
- Aspergillus (1)
- Aspirin (1)
- Assay High-resolution mass spectrometry (1)
- Assay hochauflösende Massenspektrometrie (1)
- Assays (1)
- Astrocytes (1)
- Astrozyten (1)
- Atemwegserkrankungen (1)
- Atherosclerosis (1)
- Athletes (1)
- Augmentation (1)
- Ausdauerleistung (1)
- Autophagie Lysosomale System (1)
- Autotaxin (1)
- B cells (1)
- B-phycoerythrin (1)
- BALB/c-3T3 cells (1)
- BBsome (1)
- BIOCROSS (1)
- BMP4 (1)
- BPA (1)
- BRAF (1)
- Baked products (1)
- Ballaststoffe (1)
- Barriere (1)
- Bbs4 (1)
- Be-10 dating (1)
- Beef (1)
- Benzylisothiocyanat (1)
- Beryllium (1)
- Beta-Oxidation (1)
- Beta-Oxydation (1)
- Beta-Zelle (1)
- Beta-amylase (1)
- Beta-lactoglobulin (1)
- BfR MEAL Study (1)
- Bifidobacterium (1)
- Bile Acids (1)
- Bioaktivität (1)
- Biochemical analysis (1)
- Biocompatibility (1)
- Biological Assay (1)
- Biomarkers (1)
- Bioreactor (1)
- Biotransformation (1)
- Bioverfügbarkeit (1)
- Biparietal diameter (1)
- Birds of prey (1)
- Bisphenol A (1)
- Bitter (1)
- Bittergeschmacksrezeptoren (1)
- Bitterrezeptoren (1)
- Blood flow resistance (1)
- Blood platelets (1)
- Blood protein adducts (1)
- Blood-cerebrospinal fluid barrier (1)
- Blood-liquor barrier (1)
- Blut-Hirn-Schranke (1)
- Body composition (1)
- Body weight (1)
- Body-Mass-Index (1)
- Botulinumtoxine (1)
- Brain development (1)
- Brassica (1)
- Brassica carinata (1)
- Brassica oleracea var. sabellica (1)
- Brassica rapa ssp. chinensis (1)
- Brassica vegetables (1)
- Brassicaceae (1)
- Breast cancer (1)
- Brood size (1)
- Brown adipose tissue (1)
- Brustkrebs (1)
- CAR (1)
- CD, DLS (1)
- CEHC (1)
- CKD (1)
- CLEM (1)
- COPD (1)
- CRC (1)
- CRISPR/Cas9 (1)
- CXCL10 (1)
- CXCR2 (1)
- CYP3A4 (1)
- Cachexia (1)
- Calculated free 25-hydroxyvitamin D (1)
- Calorimetry (1)
- Cameroon (1)
- Cancer prevention (1)
- Cannabidiol (CBD) (1)
- Cardiac function (1)
- Cardiac ischemia/reperfusion (1)
- Cardiac rehabilitation (1)
- Cardiovascular (1)
- Cardiovascular effects (1)
- Carobballaststoff (1)
- Carotene supplementation (1)
- Case-control study (1)
- Casein (1)
- Catabolism (1)
- Catechin (1)
- Catechins (1)
- Catecholamine (1)
- Cell culture materials (1)
- Cell proliferation (1)
- Cellular bioavailability (1)
- Cellular damage response (1)
- Cellular uptake (1)
- Cellulose acetate phthalate (1)
- Cerebellum (1)
- Chad (1)
- Chaperone (1)
- Chemerin (1)
- Chemotherapy resistance (1)
- Childhood nephrotic syndrome (1)
- Chlorogensäure (1)
- Chlorophyllide a oxygenase (1)
- Chlorophylls (1)
- Chloroplast (1)
- Cholesterol (1)
- Chronic diseases (1)
- Chronic kidney disease (1)
- Chylomicron (1)
- Claudin-4 (1)
- Clinical study (1)
- Clinical trials (1)
- Clostridium difficile (1)
- Coagulation (1)
- Cognition (1)
- Colitis (1)
- Colitis ulcerosa (1)
- Collagen (1)
- Colon cancer (1)
- Colonic microbiota (1)
- Colonkanzerogenese (1)
- Colorectal cancer (1)
- Colorectal carcinomas (1)
- Comet assay (1)
- Complement system (1)
- Complications in diabetes (1)
- Confluence (1)
- Connective tissue growth factor (1)
- Contaminants (1)
- Contamination (1)
- Contrast induced acute kidney injury (1)
- Control region (1)
- Core-multishell nanocarriers (1)
- Coronary angiography (1)
- Corticotropin-Releasing Factor Receptor Type 1 (1)
- Corticotropin-Releasing Factor Rezeptor Typ 1 (1)
- Cortisol Maternal cortisol (1)
- Cortisol vertical bar metabolism (1)
- Costs (1)
- Covalent modification (1)
- Coxsackie and Adenovirus Receptor (1)
- Coxsackie- und Adenovirus Rezeptor (1)
- Crop quality (1)
- Cross-sectional studies (1)
- Cu NP-incorporated MI-dPG coating (1)
- CuNPs (1)
- Cyp2b1 (1)
- Cyp3a11 (1)
- CypP450 (1)
- Cystic fibrosis (1)
- Cytokines (1)
- D3 cells (1)
- D3-Zellen (1)
- DAF-16 (1)
- DAF-16 transcription factor (1)
- DAIH (1)
- DASH study (1)
- DASH-Studie (1)
- DDP-4 inhibition (1)
- DNA integrity (1)
- DNA-Addukte (1)
- DNA-Reparatur (1)
- DNMT inhibitor (1)
- DNMT1 (1)
- DPP-4 inhibition (1)
- DPP-4 inhibitor (1)
- DPP-IV inhibitor (1)
- DPP4 (1)
- DPP4 inhibition (1)
- DPP4 inhibitor (1)
- Dairy biomarkers (1)
- Darmbakterien (1)
- Darmbakterium (1)
- Darmerkrankung (1)
- Darmkrebs (1)
- Darmkrebsdiagnostik (1)
- Darmlänge (1)
- Daucus (1)
- Decontamination (1)
- Delinquency (1)
- Demographic transitions (1)
- Dendritic cells (1)
- Dendritic core-multishell nanocarriers (1)
- Dengue (1)
- Depression (1)
- Derivatisation (1)
- Derivatization (1)
- Dermal delivery (1)
- Dermal drug delivery (1)
- Desensibilisierung (1)
- Determinants (1)
- Developmental programming (1)
- Diabetes incidence (1)
- Diabetes mellitus Typ 2 (1)
- Diabetes-related vascular complications (1)
- Diabetic cardiomyopathy (1)
- Diacylglycerol (DAG) (1)
- Diagnostic (1)
- Diallyl disulfide (1)
- Diarrhoea (1)
- Dichlorofluorescein assay (1)
- Dickdarmkanzerogenese (1)
- Dickdarmkrebs (1)
- Dietary Fibre (1)
- Dietary compliance (1)
- Dietary fat composition (1)
- Dietary fat replacement (1)
- Dietary sulfonates (1)
- Differential Gene Expression (1)
- Differenzierungsassay (1)
- Dipeptidyl peptidase 4 inhibitor (1)
- Dipeptidyl peptidase IV (1)
- Dipeptidyl peptidase-4 inhibition (1)
- Dipeptidylpeptidase-4 (1)
- Disease (1)
- Distal tubules (1)
- Diät (1)
- Dog growth (1)
- Dogs (1)
- Dolichol lipids (1)
- Domestic cat (1)
- Domestic cooking (1)
- Dopaminergic neurons (1)
- Dopaminergic system (1)
- Drug delivery systems (1)
- Drug metabolism (1)
- E. coli (1)
- EBI3 (1)
- EDC (1)
- ENaC (1)
- EPIC-Potsdam study (1)
- ER stress (1)
- ER-stress (1)
- EST (1)
- ETA (1)
- ETB (1)
- ETB receptor-deficient mouse (1)
- Edible insects (1)
- Eicosanoid (1)
- Electrochemistry (1)
- Electron paramagnetic resonance spectroscopy (1)
- Elektrochemie (1)
- Elemental blood serum concentration (1)
- Ellagsäure (1)
- Embryonaler Stammzelltest (EST) (1)
- Emulsifying properties (1)
- Enantio-selective reduction (1)
- Endocannabinoide (1)
- Endocrine disruption (1)
- Endodormancy (1)
- Endosomal sorting (1)
- Endothelfunktion (1)
- Endothelial dysfunction (1)
- Endothelial nitric oxide synthase (1)
- Endothelin receptor antagonists (1)
- Endothelin-1 transgenic mice (1)
- Endothelzelle (1)
- Energiehaushalt (1)
- Energy expenditure (1)
- Energy intake (1)
- Energy requirement (1)
- Enteric polymer (1)
- Enterolignanen (1)
- Enterolignans (1)
- Environmental (1)
- Enzyme (1)
- Epigallocatechingallat (1)
- Epigenetic (1)
- Epigenetik (1)
- Epstein-Barr Virus-induziertes Gen 3 (1)
- Equine metabolic syndrome (1)
- Equines (1)
- Equol (1)
- Erdnussallergie (1)
- Ernährungsmuster (1)
- Erosion kinetics (1)
- Escherichia coli (1)
- Et-1 (1)
- Ethyl cellulose (1)
- Eudragit (R) (1)
- Eudragit (R) RS (1)
- Eudragit L 100 (1)
- Euphorbia mauritanica (1)
- Euphorbiaceae (1)
- Europe (1)
- Evaluation tool (1)
- Evidence-based guideline (1)
- Excretion (1)
- Exercise tests (1)
- Experimental autoimmune encephalomyelitis (EAE) (1)
- Experimental study (1)
- Exploration (1)
- Extraction (1)
- Extrudate (1)
- FASN (1)
- FISH (1)
- FOXO1 (1)
- FVB/NJ Maus (1)
- FVB/NJ mouse (1)
- Fabaceae (1)
- Factor-Xa (1)
- Faecal bacteria (1)
- Farber disease (1)
- Fast and slow fibers (1)
- Fat infiltration in muscle (1)
- Fat-free mass (1)
- Fattening pigs (1)
- Fatty acid hydroperoxides (1)
- Fetal development (1)
- Fettinfiltration im Muskel (1)
- Fettleibigkeit (1)
- Fettsucht (1)
- Fettwahrnehmung (1)
- Fettzelle (1)
- Fetuin-A (1)
- Fibroblast growth factor 21 (1)
- Fibrosis (1)
- Fingolimod (1)
- Firefly luciferase inhibition (1)
- First trimester (1)
- Flavonoid glycosides (1)
- Flavonoide (1)
- Flavonoids (1)
- Floral scent compound (1)
- Flowering (1)
- Fluorescence lifetime imaging microscopy (1)
- Fluorescence screening (1)
- Foal (1)
- Foaming properties (1)
- Folientunnel (1)
- Food (1)
- Food Chain (1)
- Food analysis (1)
- Food authentication (1)
- Food choice (1)
- Food composition (1)
- Food labelling (1)
- Food safety (1)
- Food-exchange model (1)
- Forensic science (1)
- Formyl-Peptid Rezeptor 2 (1)
- Forster resonance energy transfer (FRET) (1)
- Frailty (1)
- Frailty criteria (1)
- Frataxin (1)
- Free radicals (1)
- Free vitamin D (1)
- Freeze-fracturing (1)
- Fremdstoffmetabolismus (1)
- Fruits (1)
- Functionality (1)
- Furosemide (1)
- G protein-coupled receptors (1)
- G-Protein gekoppelte Rezeptoren (1)
- G-Protein-gekoppelte Rezeptoren (1)
- G-protein coupled receptors (1)
- GADD45A and GADD45G (1)
- GC gene (1)
- GC-MS (1)
- GC-globulin (1)
- GLP-1 (1)
- GLUT1 XbaI gene polymorphism (1)
- GLUT8 (1)
- GOAT (1)
- GPCR (1)
- GPX (1)
- GPx2 (1)
- Gallensäuren (1)
- Gallensäurenbindung (1)
- Garlic (1)
- Gastrointestinal tract (1)
- Gehirn (1)
- Gene Array (1)
- Gene Chip (1)
- Gene expression (1)
- Gene polymorphism (1)
- Genetics (1)
- Genetik (1)
- Genexpression (1)
- Genexpressionsanalysen (qRT-PCR) (1)
- Geriatric patients (1)
- Gerontologie (1)
- Geschlecht (1)
- Geschmacksrezeptor (1)
- Getränkeauswahl (1)
- Getränkeautomat (1)
- Gewicht (1)
- Gewichtserhalt (1)
- Gewichtsreduktion (1)
- Gewichtsverlust (1)
- Ghrelin (1)
- Gliadin and glutenin fractions (1)
- Global (1)
- Glp1r(-/-) mice (1)
- Glucocorticoid receptor (1)
- Glucose intolerance (1)
- Glucose metabolism disorders (1)
- Glucose tolerance (1)
- Glucosehomöostase (1)
- Glucosetransport (1)
- Glucosinolate breakdown product (1)
- Glukoseintoleranz (1)
- Glukosestoffwechselstörungen (1)
- Glukosinolaten (1)
- Glutathion-Peroxidase (1)
- Glutathione (1)
- Gluten (1)
- Glycation (1)
- Glycemia (1)
- Glycerophospholipids (1)
- Grave’s orbitopathy (1)
- Grüner Tee (1)
- Gut microbiota (1)
- HAMP (1)
- HNRNPA1 (1)
- HOG (1)
- HOMA (1)
- HPLC-ESI-QTOF (1)
- HPLC/HR-ESMS (1)
- HPLC/ICPMS (1)
- HPMCP (1)
- HSD11B2[CA]n polymorphism (1)
- HSP70 (1)
- HaCaT cells (1)
- Hafer (1)
- Halophyten (1)
- Hautmodell (1)
- Head circumference (1)
- Health care expenditure (1)
- Health-promoting compounds (1)
- Heart failure (1)
- Heart weight (1)
- Heat aggregation (1)
- Heat shock protein 90 (1)
- Heat shock proteins (1)
- Heavy metals (1)
- Heme (1)
- Hepatic artery (1)
- Hepatic glucose balance (1)
- Hepatic hemodynamics (1)
- Hepatic insulin resistance (1)
- Hepatic lactate balance (1)
- Hepatic nerve (1)
- Hepatic stellate cells (1)
- Hepatocyte (rat) (1)
- Hepatotoxicity (1)
- Hepatotoxizität (1)
- Herd size (1)
- Herd type (1)
- Heritabilität (1)
- Herzinfarkt (1)
- Herzkreislauferkrankungen (1)
- Heterocyclic aromatic amines (1)
- Heterogeneity (1)
- High pressure - low temperature treatments (1)
- High resolution microscopy (1)
- High-resolution mass spectrometry (1)
- High-salt diet (1)
- Histologie (1)
- Hoch-Protein Diät (1)
- Hochfettdiät (1)
- Homocystein (1)
- Homologiemodellierung (1)
- Honey (1)
- Honeydew honey (1)
- Hormone (1)
- Hormonersatztherapie (1)
- Hormones (1)
- Horse (1)
- Host-plant suitability (1)
- Human (1)
- Human differentiated neurons (1)
- Human nutritional intervention (1)
- Hungerhormon (1)
- Hydroxycinnamic acids (1)
- Hydroxymethylfurfural (1)
- Hydroxymethylpyren (1)
- Hyperglycaemia (1)
- Hypertonie (1)
- Hyphenated techniques (1)
- Hypoxia (1)
- IBD (1)
- ICP-MS (1)
- ICP-QQQ-MS (1)
- IDH1 (1)
- IRAK (1)
- IgE (1)
- Imiquimod (1)
- Immediate-early-Gen (1)
- Immunhistochemie (1)
- Inactivation (1)
- Indigenous African leafy vegetables (1)
- Indole (1)
- Indoor farming (1)
- Induced pluripotent stem cells (1)
- Inductively (1)
- Inductively coupled plasma mass spectrometry (1)
- Infarct size (1)
- Inflammaging (1)
- Inflammatory skin disease (1)
- Influenza virus (1)
- Inhalation (1)
- Inorganic mercury (1)
- Insulin sensitivity (1)
- Insulin signaling (1)
- Insulin signalling (1)
- Insulin-induzierte Hypoglykämie (1)
- Insulinsekretion (1)
- Insulinsensitivität (1)
- Interactome (1)
- Intergenerational effects (1)
- Interleukin-1 (1)
- Intestinal absorption (1)
- Intimahyperplasie (1)
- Intimal Hyperplasia (1)
- Intraperitoneal administration (1)
- Iodization (1)
- Ischemia/reperfusion (1)
- Isoprostane (1)
- Isotope ratios (1)
- Isotope-dilution (1)
- Isotope-dilution analysis (1)
- Ivy (1)
- IκB (1)
- Jod (1)
- K-RAS (1)
- K-ras (1)
- Kachexie (1)
- Kaede (1)
- Kaffeenebenprodukte (1)
- Kaffeeproteine (1)
- Kaffeeverarbeitung (1)
- Kalorienrestriktion (1)
- Kalzium (1)
- Kanzerogenese (1)
- Kardiovaskuläre Erkrankungen (1)
- Kardiovaskuläre Krankheit (1)
- Katalase (1)
- Kernrezeptor (1)
- Kidney weight (1)
- Kinetik (1)
- Knock-out (1)
- Kokultur (1)
- Kolokalisation (1)
- Kolonkrebs (1)
- Konsum (1)
- Kontaktallergie (1)
- Kontrollierte klinische Studie (1)
- Kopfsalat (1)
- Kosakonia radicincitans (1)
- Krebs (1)
- Kunststoff-Additive (1)
- Kupfer (1)
- Kupfferzellen (1)
- Kurzkettige Fettsäuren (1)
- Kynurenine (1)
- Körperfett (1)
- Körpergewichsterhalt (1)
- Körpergewicht (1)
- Körpergewichtsregulation (1)
- Körpergewichtsverlust (1)
- Körpermasse (1)
- LC (1)
- LC-MS (1)
- LC-MS-MS (1)
- LC/MS/MS (1)
- LC/MS/MS; Quantification of allergenic plant traces (1)
- LEDs (1)
- LNA- clamp-PCR (1)
- LNA-clamp-PCR (1)
- LPA(3) receptor subtype (1)
- LRP8 (1)
- Labormäuse (1)
- Langerhans Zellen (1)
- Langerhans cells (1)
- Lebensmittelkette (1)
- Leg length (1)
- Legume (1)
- Lemna paucicostata (1)
- Life science (1)
- Light quality (1)
- Lignan-converting bacteria (1)
- Lignan-umwandelnde Bakterien (1)
- Lipase (1)
- Lipasen (1)
- Lipid (1)
- Lipid droplet proteome (1)
- Lipidstoffwechsel (1)
- Lipolysis (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Liquid-liquid extraction (1)
- Lithiumion battery (LIB) (1)
- Liver fat (1)
- Liver fibrosis (1)
- Liver injury (1)
- Long term health (1)
- Long-term cellular toxicity (1)
- Loop diuretics (1)
- Low birth weight (1)
- Low lean mass (1)
- Low muscle mass (1)
- Lu-Hf geochronology (1)
- Lupin (1)
- Lutein (1)
- Lutein ester (1)
- Luteinester (1)
- Lysophosphatidic acid (1)
- Lysophosphatidylcholines (1)
- MCHR-1 (1)
- MCT oil (1)
- MMF (1)
- MS quantification of leguminous additives (1)
- MSCs (1)
- MUFA (1)
- Macrovascular (1)
- Major adverse kidney event (1)
- Major royal jelly proteins (1)
- Mangan (1)
- Manganese . C. elegans (1)
- Manganism (1)
- Marker (1)
- Marker peptides (1)
- Massenspektrometrie (1)
- Mauritanicain (1)
- Measured free 25-hydroxyvitamin D (1)
- Meat peptide biomarker (1)
- Mediationsanalyse (1)
- Mediterranean Diet (1)
- Medizinprodukt (1)
- Membrane (1)
- Menderes Massif (1)
- Mesoangioblasts (1)
- Meta-analyses (1)
- Metabolically benign (1)
- Metabolism (1)
- Metabolismus (1)
- Metabolom (1)
- Metabolome analysis (1)
- Metals (1)
- Methicillin resistant Staphylococcus aureus (1)
- Method (1)
- Methylation (1)
- Methylglyoxal (1)
- MiSpEx* (1)
- Mice (1)
- Micellar caseins (1)
- MicroRNA (1)
- MicroRNAs (1)
- Microbial degradation (1)
- Microbiome (1)
- Microdialysis (1)
- Microelements (1)
- Microsatellite instability (1)
- Microsomal (1)
- Microvascular complications (1)
- Migration (1)
- Mikrobiologie (1)
- Mikrobiota (1)
- Mikronährstoffe (1)
- Mikrosomal (1)
- Milcheinnahme (1)
- Mitochondrial respiration (1)
- Mitohormesis (1)
- Mixed lymphocyte culture (MLC) (1)
- Model (1)
- Modell (1)
- Modelling (1)
- Molecular cloning and expression (1)
- Molecular structure (1)
- Molkenproteine (1)
- Monocyte (1)
- Moringa oleifera (1)
- Morphogenesis (1)
- Mortalität (1)
- Motor coordination (1)
- Motor neurons (1)
- Motorneurone (1)
- Multi-Methods (1)
- Multi-method (1)
- Multi-mycotoxin analysis (1)
- Multi-resistant bacteria (1)
- Multiple herbivory (1)
- Multiple sclerosis (1)
- Multiplex platforms (1)
- Muskelproteinumsatz (1)
- Muskelschwund (1)
- Mussel-inspired coating (1)
- Mycobacterium tuberculosis (1)
- Myoblasts (1)
- Myocardial infarction (1)
- Myocardial ischemia (1)
- Myofibroblasten (1)
- Myogenic differentiation (1)
- Myoglobin (1)
- Myrrhe (1)
- Myzus persicae (1)
- NAD booster; (1)
- NAD+ (1)
- NF-?B (1)
- NF-kB (1)
- NF-kappa B (1)
- NF-κB (1)
- NF1 (1)
- NMR-based metabolomics (1)
- NR3C1 gene (1)
- Nachkommen (1)
- Nahrung der Zukunft (1)
- Nahrungsbestandteile (1)
- Nahrungsfette (1)
- Nahrungsmittelallergie (1)
- Nahrunsgergänzungsmittel (1)
- Nanoparticle uptake (1)
- Nanoparticles (1)
- Nanotoxicology (1)
- Natriuretic peptides (1)
- Neisseria gonorrhoeae (1)
- Neoglucobrassicin (1)
- Neointima (1)
- Nephropathie (1)
- Nephropathy (1)
- Netzwerke (1)
- Neurodegeneration (1)
- Neurodevelopmental toxicity (1)
- Neurone (1)
- Neuronen (1)
- Neurons (1)
- Neuropathie (1)
- Neuropathy (1)
- Neuropeptides (1)
- Neutral lipids (1)
- New World camelids (1)
- Nif2 (1)
- Non-esterified fatty acids (NEFA) (1)
- Nordic diet (1)
- Novelose (1)
- Nuclear receptor (1)
- Nucleus tractus solitarii (1)
- Nukleosidaddukt (1)
- NutriAct family study (1)
- Nutrient stress (1)
- Nutrition-related diseases (1)
- Nutritional counseling (1)
- OCFA (1)
- Oats (1)
- Occurrence data (1)
- Ocular delivery (1)
- Odorant compounds (1)
- Offending (1)
- Offspring (1)
- Oligomere (1)
- Olivenöl (1)
- Omega-3 Fettsäuren (1)
- Omega-Hydroxylation (1)
- Omega-Hydroxylierung (1)
- Oncogenes (1)
- Ontogenetic development (1)
- Ontogeny (1)
- Optogenetik (1)
- Organic and conventional type of production (1)
- Organic arsenic (1)
- Organic carbonates (1)
- Organic mercury (1)
- Osteogenesis (1)
- Other livestock (1)
- Outcome (1)
- Oxidativer Stress (1)
- Oxidized proteins (1)
- OxyR (1)
- Oxylipin (1)
- Oxylipins (1)
- PARP (1)
- PBCEC (1)
- PBPK (1)
- PBTK (1)
- PCR-DHPLC (1)
- PCaaC38:6 (1)
- PGC1 alpha (1)
- PGC1a (1)
- PHGPx (1)
- PKM2 (1)
- PPARalpha (1)
- PRM/Alf Maus (1)
- PRM/Alf mouse (1)
- PTEN (1)
- Pancreatic cells (1)
- Pannexin 1 (1)
- Parenthood (1)
- Paternal exposure (1)
- Paternal programming; (1)
- Paternal, maternal, sex differences (1)
- Pea flour (1)
- Pea protein isolate (1)
- Peptides (1)
- Perfusion (1)
- Permeability (1)
- Peroxidatic and resolving cysteine (1)
- Peroxiredoxin (1)
- Peroxynitrite (1)
- Personalised medicine (1)
- Pest infestation (1)
- Pest-pest interaction (1)
- Pflanzliches Lignan (1)
- PhIP (1)
- Pharbitis nil cv. Violet (1)
- Pharmacokinetics (1)
- Phase II Enzyme (1)
- Phenol-amino-adducts (1)
- Phosphatidylcholines (1)
- Phosphatidylinositols (1)
- Phosphoenolpyruvate carboxykinase (1)
- Phospholipids (1)
- Photosynthesis (1)
- Physical activity (1)
- Physicochemical properties (1)
- Physiologie (1)
- Pig (1)
- Pilot-Studie (1)
- PlGF (1)
- Plant allergen (soy, sesame, lupine) (1)
- Plant authentication (1)
- Plant growth promoting bacteria (1)
- Plant lignan (1)
- Plasma (1)
- Plasma concentration (1)
- Plasmalogens (1)
- Platelets (1)
- Polyamine (1)
- Polymeric nanoparticle (1)
- Polymeric nanoparticles (1)
- Polyphenols (1)
- Polyubiquitination (1)
- Ponderostat (1)
- Pooling analysis (1)
- Portal vein (1)
- Post-translational modifications (1)
- Post-translational protein modification (1)
- Postharvest processing (1)
- Preadipozyt (1)
- Precision medicine (1)
- Precision prognostics (1)
- Preeclampsia (1)
- Pregnane X Receptor (1)
- Preinterventional biomarker (1)
- Presystemic metabolism (1)
- Preterm birth (1)
- Preterm delivery (1)
- Primary care (1)
- Principal component analysis (1)
- Probiotika (1)
- Procyanidins (1)
- Proliferation (1)
- Prostaglandin (1)
- Prostaglandin E₂ (1)
- Prostaglandin receptor (1)
- Prostaglandin receptor EP4 (1)
- Prostaglandine (1)
- Proteasomal system (1)
- Proteasome and lysosome (1)
- Protein (1)
- Protein Modifizierung (1)
- Protein aggregates (1)
- Protein functionality and modification (1)
- Protein intake (1)
- Protein-Wechselwirkungen (1)
- Proteine (1)
- Proteinmodifizierung (1)
- Proteolysis (1)
- Proteome (1)
- Proteostase (1)
- Proteostasis (1)
- Prävention (1)
- Pseudomonas aeruginosa (1)
- Psoriasis (1)
- Pulmonary arterial hypertension (1)
- Pulse wave velocity (1)
- Punktmutation (1)
- Purification (1)
- Pyrrolizidine alkaloids (1)
- QSAR (1)
- QTL (1)
- Quality appraisal (1)
- Quantification of peptides (1)
- Quercetin (1)
- RAW 264 (1)
- RBP (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- ROS (1)
- Radiocontrast media-induced nephropathy (1)
- Raman spectroscopy (1)
- Rat (1)
- Ratte (1)
- Rauchen (1)
- Reactive Oxygen Species (1)
- Reaktive Sauerstoffspezies (1)
- Recycling (1)
- Redox (1)
- Redox control (1)
- Redox homeostasis (1)
- Redox regulation (1)
- Reduktase (1)
- Reference intervals (1)
- Refinement (1)
- Regionality (1)
- Regulatory T cells (Treg) (1)
- Reh (1)
- Relaxin (1)
- Reliability (1)
- Renin-angiotensin system (1)
- Renin-angiotensin-aldosterone system (1)
- Reportergen-Assay (1)
- Resistance (1)
- Resistant starch (1)
- Retinoblastoma (1)
- Retinol (1)
- Retinol-Bindungsprotein 4 (1)
- Retinol-binding protein 4 (1)
- Retinopathie (1)
- Rezeptoren (1)
- Rezeptorscreening (1)
- Rheologie (1)
- Risikobewertungen (1)
- Risikoeinschätzung (1)
- Risk (1)
- Risk factor (1)
- Risk prediction (1)
- Risk prediction model (1)
- Risk score (1)
- Root exudates (1)
- Rosa x level (1)
- Rye (1)
- S1P receptors (1)
- S1P(3) receptor (1)
- SARS CoV-2 host factors (1)
- SCID mice (1)
- SEC-HPLC (1)
- SELENOH (1)
- SEM (1)
- SGK-1 (1)
- SGLT2 blocker (1)
- SNARE proteins (1)
- SREBP-1c (1)
- SSCP (1)
- ST-1071 (1)
- ST-1893 (1)
- ST-1894 (1)
- ST-968 (1)
- STED (1)
- SU5416 (1)
- SULT1A1 (1)
- SULT1A2 (1)
- SVM (1)
- Saccharomyces boulardii (1)
- Safety (1)
- Salicin (1)
- Saline Landwirtschaft (1)
- Salzgeschmack (1)
- Sarkopenie (1)
- Schilddrüse (1)
- Schilddrüsenautoimmunerkrankungen (1)
- Schlaganfall (1)
- Schwerkraft (1)
- Se-methylselenoneine (1)
- Seafood (1)
- Seasonality (1)
- Secondary metabolites (1)
- Selenonein (1)
- Selenoneine (1)
- Selenoprotein (1)
- Selenosugar 1 (1)
- Senescence (1)
- Sensorik (1)
- Serine and trypsin protease (1)
- Serotonin (1)
- Set-Point (1)
- Sex ratio at birth (1)
- Sexual dimorphism (1)
- Shan He Jian Fei Granules (SHJFG) (1)
- Short chain dehydrogenase (1)
- Short stature (1)
- Side effects (1)
- Signal transduction (1)
- Signaling pathways (1)
- Signalübertragung (1)
- Single nucleotide polymorphism (1)
- Skelettmuskel (1)
- Skelettmuskelalterung (1)
- Skin (1)
- Skin barrier disruption (1)
- Skin model (1)
- Slatted floor (1)
- Small molecules (1)
- Small selenium species (1)
- Smooth muscle cells (1)
- Sojabohne (1)
- Solanum scabrum (1)
- Speciation (1)
- Species differences (1)
- Spectrophotometry (1)
- Speichel (1)
- Spelt (1)
- Spermienmotilität (1)
- Sphingomyelin (1)
- Sphingosine 1-phosphate (S1P) (1)
- Sphingosine 1phosphate (1)
- Sphingosine kinase-1 (1)
- Sphingosine-1-phosphate lyase (1)
- Spirulina (1)
- Sport (1)
- Spurenelement (1)
- Spurenelemente (1)
- Stammzelle (1)
- Starvation (1)
- Stereotypien (1)
- Stickstoffmonoxid (1)
- Stillbirth (1)
- Stoffwechselhormone (1)
- Stoffwechselkäfig (1)
- Stroke (1)
- Stromal cell-derived factor-1 (1)
- Structural changes (1)
- Study protocol (1)
- Styrol (1)
- Substratverwertung (1)
- Sucrose (1)
- Sulfid (1)
- Sulfonate (1)
- Sulfoquinovose (1)
- Superoxiddismutase (1)
- Susceptibility-genes (1)
- Suszeptibilitätsgene (1)
- Swine (1)
- Synbiotika (1)
- Synthesis (1)
- Säugetiere ; Fettgewebe ; Zelldifferenzierung ; Genexpression (1)
- Säuglingsnahrung (1)
- Süßgeschmack (1)
- Süßrezeptor (1)
- Süßstoff (1)
- T helper 17 cells (1)
- T2D (1)
- TAVI (1)
- TEAC (1)
- TET (1)
- TFA (1)
- TGF-beta (1)
- TGF-beta 1 (1)
- TNF alpha (1)
- TRPV5 (1)
- TRPV6 (1)
- TTC (1)
- TTR (1)
- Tagetes (1)
- Tas1r1 (1)
- Tas2r (1)
- Tas2rs (1)
- Taurocholate (1)
- Tea leaves (1)
- Technique (1)
- Technofunctional properties (1)
- Teecatechin (1)
- Testicle (1)
- Tetranychus urticae (1)
- Th17 (1)
- Thai population (1)
- Thermal and nonthermal treatment (1)
- Thermal processing (1)
- Thin layer chromatography (1)
- Thio-arsenosugar-glycerol (1)
- Thio-dimethylarsinic acid (1)
- Thiol (1)
- Thiol-dependent peroxidase (1)
- Thiolmodifikation (1)
- Thioredoxin reductase (1)
- Three phase partitioning (1)
- Thrifty phenotype (1)
- Thyroid hormone (1)
- Tierarzneimittel (1)
- Tierschutz (1)
- Tight Junctions (1)
- ToF-SIMS (1)
- ToF-SIMS imaging (1)
- Tocopherol (1)
- Tocotrienol (1)
- Tocotrienols (1)
- Total arsenic (1)
- Total diet study (1)
- Toxicokinetics (1)
- Toxikokinetik (1)
- TraceAge (1)
- Trans-Fettsäuren (1)
- Trans-epoxy-fatty acid (1)
- Transactivation assay (1)
- Transcatheter Aortic Valve Implantation (1)
- Transcriptomics (1)
- Transformation product (1)
- Transformationsprodukt (1)
- Transforming Growth Factor beta (1)
- Transforming growth factor beta (1)
- Transkriptionsfaktor (1)
- Transkriptom (1)
- Transmembrane asymmetry (1)
- Transmission (1)
- Transplantation (1)
- Triglyceride secretion (1)
- Trunk length (1)
- Tumor (1)
- Tumor necrosis factor alpha (1)
- Tumour suppressor genes (1)
- Tween40 micelles (1)
- Twister (TM) (1)
- Twister TM (1)
- Typ 2 Diabetes (1)
- Type-2-diabetes (1)
- UDP-glucuronosyltransferase (1)
- UV light (1)
- Ubiquitin Proteasom System (1)
- Ulcerative colitis (1)
- Umbilical artery Doppler (1)
- Umbrella review (1)
- Uncoupling proteins (1)
- Unprepared and (1)
- Urate (1)
- Urinary ET-1 (1)
- Urine excretion (1)
- Uruguay River (1)
- VCAM-1 (1)
- VOC (1)
- Validation (1)
- Vascular stiffness (1)
- Vegan (1)
- Verhaltensstudien (1)
- Versuchstierkunde (1)
- Very low birth weight infant (1)
- Veterinary drugs (1)
- Vineatrol (R) 30 (1)
- Vitamin A supplementation (1)
- Vitamin C (1)
- Vitamin D (1)
- Vitamin D binding protein (1)
- Vitamin D deficiency (1)
- Vitamin D insufficiency (1)
- Vitamin D-binding protein (1)
- Vitellogenin (1)
- Volatile compound (1)
- WAT (1)
- WHO (1)
- Warburg effect (1)
- Water and salt retention (1)
- Weight change (1)
- Wheat (1)
- Whey proteins (1)
- Wiederkäuer (1)
- Wnt pathway (1)
- Wnt-Signalweg (1)
- World Cancer Research Fund/American Institute for Cancer Research Recommendations (1)
- Xenobesity (1)
- Y:X chromosome ratio (1)
- YB-1 (1)
- Yolk (1)
- Zellkulturen (1)
- Zelllinien (1)
- Zellproliferation (1)
- Zink (1)
- Zinypr-1 (1)
- Zirkadianer Rhythmus (1)
- Zoonoses (1)
- Zwillingsstudie (1)
- Zytokine (1)
- Zytotoxizitätsassay (1)
- [N-15]Anthranilic acid (1)
- [N-15]Indole (1)
- a-tocopherol (1)
- absorption (1)
- accretionary wedge (1)
- acetate (1)
- activity-regulated cytoskeleton-associated protein (1)
- acute inflammation (1)
- ad libitum consumption (1)
- ad libitum-Verzehr (1)
- adduct formation (1)
- adenylate-cyclase (1)
- adipocyte (1)
- advanced glycation endproducts (1)
- aggregated immunoglobulin-g (1)
- agonists interaction (1)
- air pollution (1)
- air-dried (1)
- air-fried (1)
- akute Entzündung (1)
- alcohol (1)
- alcohol dehydrogenase (1)
- alcohol intake (1)
- alcylated polycyclic aromatic hydrocarbons (1)
- aldehyde dehydrogenase (1)
- alkylated polycyclic aromatic hydrocarbons (1)
- alkylating agents (1)
- allometric model (1)
- alpha-Catenin (1)
- alpha-SMA (1)
- alpha-Tocopherol (1)
- alpha-tocopherol (1)
- alpha-tocopherol transfer protein (Ttpa) (1)
- alternative splicing (1)
- alternative zu Tierversuchen (1)
- amaranth (1)
- amino acid score (1)
- amino acids (1)
- amitriptyline (1)
- amylase activity (1)
- analytical methods (1)
- anaphylaxis (1)
- and nutrition (1)
- angiotensin (1-7) (1)
- angiotensin II (1)
- anti-inflammatory therapy (1)
- antibacterial aerosol (1)
- antibacterial effect (1)
- antibakterielles Aerosol (1)
- anticancer (1)
- antidiabetic drug (1)
- antifogging additives (1)
- antioxidant activity (1)
- antioxidant defense systems (1)
- antioxidant potential (1)
- antioxidative capacity (1)
- antioxidative phenolic ingredients (1)
- anxiety sensitivity (1)
- aphids (1)
- appetite regulation (1)
- arabinoxylan (1)
- arachidonic-acid (1)
- aroma quality (1)
- aromatic amines; sulfotransferases; mutagenicity; bioactivation (1)
- aromatische Amine; Sulfotransferasen; Mutagenität; Bioaktivierung (1)
- arsenic (1)
- arsenolipids (1)
- artificial (1)
- astrocytes (1)
- asymmetric dimethylarginine (1)
- asymmetric dimethylarginine (ADMA) (1)
- asymmetrisches Dimethylarginin (1)
- atmospheric deposition (1)
- auditory neurons (1)
- autofluorescence (1)
- autoimmunity (1)
- autophagy flux (1)
- autophagy lysosomal system (1)
- b-Catenin (1)
- barrier (1)
- behavioral experiments (1)
- behaviour (1)
- benzylic sulfate (1)
- benzylic sulfuric acid ester (1)
- benzylischer Schwefelsäureester (1)
- benzylisches Sulfat (1)
- benzylisothiocyanate (1)
- beta-Lactoglobulin (1)
- beta-carotene (1)
- beta-carotene hydroxylase (1)
- beta-cell loss (1)
- beta-cells (1)
- beverage (1)
- bifidobacterium (1)
- bile acids (1)
- bioactive peptides (1)
- bioactivity (1)
- bioencapsulation (1)
- biomarkers (1)
- biomarkers of renal failure (1)
- biotransformation (1)
- birds of prey (1)
- birthweight (1)
- bladder cancer cells (1)
- blood banking (1)
- blood biomarker (1)
- blood-brain barrier (1)
- blood– brain barrier (1)
- blood– cerebrospinal fluid barrier (1)
- body composition (1)
- body mass (1)
- body weight (1)
- body weight loss (1)
- body weight maintenance (1)
- bone (1)
- bone mineral density (1)
- bovine milk (1)
- brain-gut axis (1)
- branched chain amino acids (1)
- braunes Fettgewebe (1)
- breast cancer (1)
- broiler chicks (1)
- brown adipose tissue (1)
- browning (1)
- burn injury (1)
- c-Fos (1)
- cachexia (1)
- caenorhabditis elegans (1)
- caffeic acid derivatives (1)
- calbindin D9k (1)
- calcitriol (1)
- calcium imaging (1)
- calcium transport (1)
- caloric restriction (1)
- cancer cells (1)
- cancer stem cells (1)
- canine osteoarthritis (1)
- cannabidiol (CBD) (1)
- capillary blood (1)
- caquexia (1)
- carbon sequestration (1)
- carcinogenesis (1)
- cardiac inflammaging (1)
- cardiac progenitor migration and differentiation (1)
- cardiokine (1)
- cardiometabolic diseases (1)
- cardiovascular risk (1)
- carob fibre (1)
- carota L (1)
- carotene (1)
- carotenoids bioavailability (1)
- catFISH (1)
- catalase (1)
- cell cuture (1)
- cell cycle (1)
- cell line (1)
- cell migration (1)
- cell transformation assay (1)
- cell wall deficient mutant (1)
- cell-based in vitro assay (1)
- cell-death (1)
- cellular uptake (1)
- central nervous system (1)
- cerebellum (1)
- chemokines (1)
- chick embryo (1)
- children (1)
- chimpanzee (1)
- chlorbenzol (1)
- chlorogenic acid (1)
- chlorophylls (1)
- chronic and acute inflammation (1)
- chronic disease (1)
- chronic renal failure (1)
- chronic renal failure in children (1)
- cilium (1)
- circulation (1)
- classification (1)
- claudin-4 (1)
- click chemistry (1)
- clinical prediction rule (1)
- clinical sample (1)
- clinical studies (1)
- clinical trial (1)
- cocoa processing (1)
- cocoa proteins (1)
- coffee proteins (1)
- cold atmospheric pressure plasma (1)
- collagen I (1)
- colocalisation study (1)
- colon cancer (1)
- colon cancer diagnosis (1)
- color (1)
- color preference (1)
- color vision (1)
- colorectal carcinoma (1)
- colorectal neoplasm (1)
- colostrum (1)
- colour (1)
- commensal (1)
- comparison (1)
- complement (1)
- complication (1)
- complications (1)
- constitutive androstane receptor (1)
- construct validity (1)
- contrast-induced nephropathy (1)
- core (1)
- core-multishell (CMS) nanocarriers (1)
- cost-effectiveness analysis (1)
- coupled plasma mass spectrometry (1)
- cow's milk (1)
- cow-side assay (1)
- crop (1)
- curcumin (1)
- cystic fibrosis (1)
- cytotoxicity (1)
- cytotoxicity assay (1)
- d-Loop (1)
- dairy intake (1)
- decision tree (1)
- decitabine (1)
- deep-fried (1)
- dendritic cell (1)
- dendritic polyglycerol (1)
- depression (1)
- dermal drug administration (1)
- desensitization (1)
- diatoms (1)
- dichlorbenzol (1)
- dichlorobenzene (1)
- diet quality (1)
- diet score (1)
- diet selection (1)
- diet-disease association (1)
- dietary antioxidants (1)
- dietary choices (1)
- dietary citric acid (1)
- dietary factors (1)
- dietary fibre (1)
- dietary guidelines (1)
- dietary lipids (1)
- dietary sulfonates (1)
- dietary supplements (1)
- differentiation assay (1)
- disproportional intrauterine growth retardation (1)
- distal convoluted tubule (1)
- distress (1)
- diurnal rhythm (1)
- diätetische Antioxidantien (1)
- dog (1)
- domestic cooking (1)
- dosage recommendation (1)
- drug delivery systems (1)
- drug design (1)
- drug metabolism (1)
- drug-resistant bacteria (1)
- dysfunction (1)
- e-Zigarette (1)
- e-cigarette (1)
- eating (1)
- eating disorder symptoms (1)
- echocardiography (1)
- egg yolk (1)
- electron microscopy (1)
- electronic drug delivery system (EDDS) (1)
- electronic nicotin delivery system (ENDS) (1)
- ellagic acid (1)
- embryonic stem cell test (EST) (1)
- emotionality (1)
- emulsion (1)
- endocannabinoids (1)
- endocrine disruption (1)
- endocytosis (1)
- endothelabhängige flussinduzierte Vasodilatation (1)
- endothelial cell (1)
- endothelial function (1)
- endothelin-converting enzyme (1)
- energy (1)
- energy expenditure (1)
- energy harvest (1)
- environmental DNA (1)
- environmental impact (1)
- enzyme assays (1)
- enzyme induction (1)
- enzymes (1)
- epigallocatechin gallate (1)
- epigenetic (1)
- equol (1)
- essential oils (1)
- etanercept (1)
- etiology (1)
- exercise performance (1)
- experimental antigen-induced encephalomyelitis (1)
- exposure (1)
- expression analysis (1)
- extinction (1)
- extra-cellular matrix (1)
- extracellular matrix (1)
- extraction and characterization methods (1)
- extrazelluläre Matrix (1)
- factor structure (1)
- failure (1)
- fasting blood glucose (1)
- fat metabolism (1)
- fat perception (1)
- fat-soluble vitamin (1)
- fatigue (1)
- fatty acid profile (1)
- fatty acid synthesis (1)
- fatty pancreas (1)
- female (1)
- fermentation-related enzymes (1)
- fetal programing (1)
- fetal sex (1)
- fiber (1)
- filter paper (1)
- fingolimod (1)
- first trimester (1)
- flow (1)
- fluorescent probe (1)
- fluvial terraces (1)
- foal (1)
- food (1)
- food allergy (1)
- food group consumption (1)
- food groups (1)
- food safety (1)
- foot and mouth disease (HFMD) (1)
- formyl peptide receptor 2 (1)
- fortification (1)
- frailty (1)
- frataxin (1)
- free radicals (1)
- free zinc (1)
- fruit metabolites (1)
- functional diversity (1)
- functional properties (1)
- funktionelle Variabilität (1)
- furin cleavage site (1)
- future food (1)
- fígado (1)
- garnet (1)
- gender (1)
- gene (1)
- gene expression analysis (qRT-PCR) (1)
- gene regulation (1)
- gene-lifestyle interaction (1)
- genetic variants (1)
- genetics (1)
- genomic instability (1)
- genomics (1)
- genomische Instabilität (1)
- gerontology (1)
- geschützter Anbau (1)
- gestational diabetes mellitus (1)
- gestational diabetes mellitus (GDM) (1)
- girths and breadths (1)
- glasswort (1)
- gliptins (1)
- glomerular arterioles (1)
- glucose homeostasis (1)
- glucose transport (1)
- glycation (1)
- glycemic control (1)
- glycemic control during pregnancy (1)
- glycogen synthase kinase-3 (1)
- glycosylation (1)
- gold nanostars (1)
- grafische Modelle (1)
- graphical models (1)
- gravity (1)
- green tea (1)
- green tea phenols (1)
- greenhouse gas emissions (1)
- groEL (1)
- growth (1)
- gut length (1)
- hTAS2R10 (1)
- haemodialysis (1)
- hand (1)
- haplotype (1)
- health (1)
- health risks (1)
- health span (1)
- healthy subjects (1)
- heart tube (1)
- heart-type fatty acid binding protein (1)
- heat shock proteins (1)
- heath potentials (1)
- heme (1)
- hemodialysis (1)
- hepatic impairment (1)
- hepatic retinol mobilization (1)
- hepatocellular carcinoma (1)
- hepatocyte (1)
- hepatotoxicity (1)
- heptadecanoic acid (C17:0) (1)
- heritability (1)
- heterocyclic aromatic amine (1)
- heterocyclic aromatic amines (1)
- heterocyclisches aromatisches Amin (1)
- heterologe Expression (1)
- heterologous expression (1)
- heterozyklische aromatische Amine (1)
- high fat diet (1)
- high salt (1)
- high-density lipoprotein (HDL) (1)
- high-fat diet (1)
- high-resolution imaging (1)
- hippocampus (1)
- homocysteine (1)
- homology modelling (1)
- hormones (1)
- human body composition (1)
- human diet (1)
- human follicular fluid (1)
- human health (1)
- human liver microsomes (1)
- human milk (1)
- human nutrition (1)
- hunger hormone (1)
- hydroxymethylfurfural (1)
- hydroxymethylpyrene (1)
- hyperglycemia (1)
- hypotension (1)
- hypoxic pulmonary vasoconstriction (1)
- hypoxische pulmonale Vasokonstriktion (1)
- immediate early gene (1)
- immune (1)
- immune response (1)
- immune system (1)
- immune-inflammatory biomarkers (1)
- immunoblot (1)
- immunohistochemistry (1)
- immunomodulator (1)
- impaired glucose tolerance (1)
- in silico (1)
- in situ chemical reduction (1)
- in vitro blood-brain barrier model (1)
- in vivo (1)
- incident type 2 diabetes (1)
- increases (1)
- index (1)
- indigenous leafy vegetables (1)
- indoor farming (1)
- induced pluripotent stem cells (1)
- induction (1)
- induzierte pluripotente Stammzellen (1)
- inflamação (1)
- inflammatory bowel disease (1)
- inhalative Applikation (1)
- inhibitory cytokines (1)
- inorganic mercury (1)
- insect proteins (1)
- insulin signalling (1)
- insulin-induced hypoglycemia (1)
- insulina (1)
- insulinresistance (1)
- integrated stress response (1)
- integrins (1)
- intercellular communication (1)
- intercropping (1)
- interleukin-1 (1)
- interleukin-35 (1)
- interventions (1)
- intesinal disease (1)
- intestinal (1)
- intestinal epithelial cells (1)
- intestinal inflammation (1)
- intestinal model (1)
- intestinale Epithelzellen (1)
- intestinale Mikrobiota (1)
- intrauterine (1)
- intrauterine fetal growth (1)
- inulin (1)
- invasion (1)
- involuntary weight loss (1)
- iodine (1)
- ion chromatography (1)
- ion quantification (1)
- ionophore antibiotics (1)
- iron (1)
- ischemia reperfusion injury (1)
- isoflavones (1)
- isothiocyanate (1)
- kale (1)
- kappa-casein (1)
- kardiovaskuläres Risiko (1)
- ki-ras (1)
- kidney dysfunction (1)
- kidney injury molecule 1 (1)
- kinetics (1)
- knock-out (1)
- kolorektales Karzinom (1)
- kurzkettige Fettsäuren (1)
- körperliche Aktivität (1)
- laboratory animal sciences (1)
- lactate output (1)
- lactobacillus (1)
- lake sediments (1)
- land use (1)
- land-based aquaculture (1)
- langsame und schnelle Fasertypen (1)
- large for gestational age fetus (LGA) (1)
- large population (1)
- large sample size studies (1)
- latex (1)
- lettuce (1)
- leucine (1)
- leukocyte-endothelial interaction (1)
- life cycle toxicities (1)
- life style (1)
- lifestyle risk reduction (1)
- limb lengths (1)
- lineage commitment (1)
- linear gemischte Modelle (1)
- linear mixed models (1)
- lipases (1)
- lipid (1)
- lipid analysis (1)
- lipid droplets (1)
- lipids (1)
- lipophagy (1)
- liposomes (1)
- litter decomposition (1)
- liver disease (1)
- liver regeneration (1)
- liver toxicity (1)
- liver-targeting PLUS peptide (1)
- locus of control (1)
- long chain base (1)
- long-chain polyunsaturated fatty acids (1)
- longevity (1)
- longitudinal analysis (1)
- low birth weight (LBW) (1)
- low molecular weight selenium species (1)
- low temperature (1)
- low-grade inflammation (1)
- lower nephron (1)
- lower respiratory tract infections (LRTIs) (1)
- lung cancer (1)
- lung inflammation (1)
- lupin (1)
- lutein ester (1)
- lutein esters (1)
- lycopene (1)
- lymphopenia (1)
- lysosomal storage disorders (1)
- lysozyme (1)
- lysozyme activity (1)
- mPGES (1)
- mRNA degradation (1)
- machine learning (1)
- macroarray (1)
- macrophage (1)
- macrovascular complications (1)
- macrófagos (1)
- macular pigment density (1)
- makrovaskuläre Komplikationen (1)
- male (1)
- malignant transformation (1)
- maligne Transformation (1)
- mare (1)
- mastery (1)
- maternal diet (1)
- maternale Ernährung (1)
- matrix metalloproteinases (1)
- maturity (1)
- mealworm (1)
- measles virus (1)
- mediation analysis (1)
- mediterrane Ernährung (1)
- membrane analysis (1)
- membrane lipids (1)
- membrane-lipid therapy (1)
- menschliche Ernährung (1)
- mercuric mercury (1)
- metablism (1)
- metabolic response (1)
- metabolischer Stress (1)
- metabolisches Syndrom (1)
- methionine restriction (1)
- method development (1)
- method validation (1)
- methyl jasmonate (1)
- miRNAs (1)
- microRNAs (1)
- microbial mining (1)
- microbiology (1)
- microbiome (1)
- microbiomics (1)
- microbiota (1)
- microgreen (1)
- micronutrient (1)
- micronutrient deficiencies (1)
- microorganisms (1)
- microparticle (1)
- microplastics (1)
- microscope (1)
- microwave-assisted extraction (1)
- migration (1)
- mikrovaskuläre Komplikationen (1)
- mitochondria, (1)
- mitochondrial homeostasis (1)
- mixtures (1)
- molecular dynamics (1)
- molecular modeling (1)
- molecular pathways (1)
- monochlorobenzene (1)
- morpholino analogues of fingolimod (1)
- motor neurons (1)
- mouse models (1)
- moxidectin (1)
- mtDNA (1)
- mucus (1)
- multiple sclerosis (1)
- muscle (1)
- muscle atrophy (1)
- muscle fibre composition (1)
- muscle fibre type (1)
- muscle mass (1)
- muscle metabolism (1)
- muscle protein turnover (1)
- muscle wasting (1)
- mustard agents (1)
- mustards (1)
- myofibroblast (1)
- myoglobin (1)
- myokine (1)
- myrrh (1)
- n-3 fatty acid (1)
- n-6 fatty acid (1)
- n-oxPTH (1)
- narrow-banded UVB (1)
- natural compounds (1)
- nephrin (1)
- nephropathy (1)
- network (1)
- networks (1)
- neurofibromatosis (1)
- neuron (1)
- neurons (1)
- neuropathy (1)
- neuropeptides (1)
- neutral endopeptidase (1)
- neutrophil chemotaxis (1)
- neutrophil gelatinase-associated lipocalin (1)
- new analysis method (1)
- nicotinamide adenine dinucleotide (1)
- nicotinamide riboside (1)
- nomadic pastoralist (1)
- non-alcoholic steatohepatitis (1)
- nonlinear microscopy (1)
- nuclear receptor (1)
- nucleosidadduct (1)
- nucleus of the solitary tract (1)
- nukleärer Rezeptor (1)
- nutrient bioavailability (1)
- nutrition security (1)
- nutritional factors (1)
- nutritional supplements (1)
- old adults (1)
- oligomers (1)
- omega-3 fatty acid (1)
- one dot two development signals (ODTDS) dot blot (1)
- ontogeny (1)
- operant behavior (1)
- optimization (1)
- optogenetic (1)
- oral immunotherapy (1)
- orale Immuntherapie (1)
- orangutan (1)
- organ failure (1)
- organic mercury (1)
- orphan crops (1)
- osteoblast (1)
- osteopontin (1)
- osteoporosis (1)
- osterix (1)
- outcome (1)
- ovarian cancer (1)
- oxidation (1)
- oxidativer Stress (1)
- p-AKT (1)
- p-mTOR (1)
- p53 signaling (1)
- p53 targets (1)
- pH-sensitive nanoparticle (1)
- pH-sensitive nanoparticles (1)
- palm oil (1)
- paternal programming (1)
- pathogen (1)
- peanut allergy (1)
- penetration enhancement (1)
- pentadecanoic acid (C15:0) (1)
- peptide (1)
- performance (1)
- perfused-rat-liver (1)
- peripheral nervous system (1)
- peripheres Nervensystem (1)
- perturbation (1)
- pflanzliche Sekundär Metabolite (1)
- phase II enzymes (1)
- phenol nitration (1)
- phenol oxidation (1)
- phenols (1)
- phosphorus (1)
- phosphorylation (1)
- photochemistry (1)
- photosynthesis (1)
- photothermal therapy (1)
- phthalates (1)
- physiology (1)
- phytochemicals (1)
- pilot study (1)
- placenta (1)
- plant drinks (1)
- plant growth-promoting bacteria (1)
- plant phenolic compounds (1)
- plant protease (1)
- plant secondary metabolites (1)
- plant-based diets (1)
- plasma membrane (1)
- plasma process indicators (1)
- plastic additives (1)
- point mutation (1)
- pollution (1)
- poly ungesättigte Fettsäuren (1)
- poly(ADP-ribose) polymerase-1 (1)
- poly(ADP-ribosylation) (1)
- polyamines (1)
- polycystic kidney disease (1)
- polycystic ovary syndrome (1)
- polytunnel (1)
- polyunsaturated fatty acids (1)
- ponderostat (1)
- porphyridium purpureum (1)
- positional cloning (1)
- post-hospital syndrome (1)
- post-menopausal Thai women (1)
- post-translational modifications (1)
- postmenopausal (1)
- postprandial response (1)
- postprandial study (1)
- potassium iodate (1)
- potency assessment (1)
- preadipocyte (1)
- prebiotics (1)
- pregnancy induced diabetes (1)
- pregnane X-receptor (1)
- prepared foods (1)
- presystemic metabolism (1)
- preterm delivery (1)
- preterm infant (1)
- preventive measures (1)
- primary immunodeficiencies (1)
- priming effect (1)
- principal component analysis (1)
- proinsulin (1)
- proline rich proteins (1)
- prolinreiche Proteine (1)
- propionate (1)
- prostaglandin receptor (1)
- prostaglandin-f2-alpha (1)
- prostaglandine (1)
- prostate cancer (1)
- protected cultivation (1)
- protein derivatization (1)
- protein digestibility (1)
- protein interactions (1)
- protein microheterogeneity (1)
- protein pattern (1)
- protein quantification (1)
- protein-phenol binding (1)
- protein-phenol interactions (1)
- proteomix analysis (1)
- pulmonalarterielle glatte Muskelzellen (1)
- pulmonary artery smooth muscle cells (1)
- qPCR-based gene expression screening (1)
- quality control (1)
- quantitativ (1)
- quantitative (1)
- quercetin (1)
- ramipril (1)
- randomisierte Studie (1)
- randomized controlled intervention study (1)
- randomized controlled trial (1)
- rapeseed protein (1)
- rapid detection method (1)
- reactive oxygen and nitrogen species (1)
- reactive oxygen species (1)
- real life context (1)
- receptor (1)
- red wine (1)
- redox (1)
- redox homeostasis (1)
- reductase (1)
- reflection spectroscopy (1)
- regional diets (1)
- regulatory T cells (1)
- regulatory monitoring (1)
- relative dose response test (1)
- reliability; (1)
- renal dysfunction (1)
- renal function (1)
- renal haemodynamics (1)
- repair (1)
- repeated measures design (1)
- replication (1)
- reporter gene assay (1)
- reproducibility (1)
- resistência à insulina (1)
- respiratory diseases (1)
- resveratrol (1)
- resveratrol oligomers (1)
- retinoic acid (1)
- retinoid homeostasis (1)
- retinoids (1)
- retinol (ROH) (1)
- retinol binding protein 4 (1)
- retinol-binding protein (1)
- retinopathy (1)
- retinyl ester storage (1)
- retinyl esters (1)
- retinyl palmitate (1)
- risk assessment (1)
- risk factors (1)
- risk score (1)
- risk scores (1)
- roe deer (1)
- ruminant (1)
- ruminants (1)
- sFlt-1 (1)
- safety efficacy (1)
- salinomycin (1)
- saliva proteins (1)
- salivary proteins (1)
- salmon fish (1)
- salt composition (1)
- salt taste perception (1)
- scores (1)
- screening (1)
- scrub typhus (1)
- seawater (1)
- sekundäre Pflanzenstoffe (1)
- selenium transport (1)
- selenoprotein (1)
- sensory analysis (1)
- sepsis (1)
- serine protease (1)
- serum amyloid A (SAA) (1)
- serum retinol binding protein (RBP4) (1)
- set-point (1)
- short chain fatty acids (1)
- shortening rate (1)
- single nucleotide polymorphism (1)
- single-cell analysis (1)
- situation (1)
- skeletal muscle aging (1)
- skeletal-muscle (1)
- skin (1)
- skin equivalents (1)
- slow and fast fiber types (1)
- smartphone (1)
- smoking (1)
- snacking (1)
- sodium (1)
- soy (1)
- soy isoflavones (1)
- spectrophotometry (1)
- sperm motility (1)
- spermatogenesis (1)
- sphingomyelin phosphodiesterase 1 (1)
- sphingosine kinase-1 (1)
- sphingosine kinases (1)
- sphingosine-1-phosphate (S1P) (1)
- spider mites (1)
- starter formula (1)
- stem cell (1)
- stereotypy (1)
- stomach model (1)
- storage (1)
- styrene (1)
- suPAR (1)
- substrate utilisation (1)
- succession (1)
- sudden death (1)
- sulfide (1)
- sulforaphan (1)
- sulforaphane (1)
- sulfur mustard (1)
- superoxide dismutase (1)
- suppressor of cytokine signaling (SOCS) (1)
- sweet taste (1)
- sweet taste receptor (1)
- sweetener (1)
- synbiotics (1)
- synovial fluid (1)
- systematischer Review (1)
- systemic response (1)
- systolic function (1)
- síndrome metabólica (1)
- tacrolimus (1)
- tannin binding salivary proteins (1)
- tannin-protein interaction (1)
- tanninbindende Speichelproteine (1)
- targeted metabolomics (1)
- taste receptor (1)
- taste receptor screening (1)
- tea catechin (1)
- tea processing (1)
- telbivudine (1)
- telmisartan (1)
- terpenoids (1)
- therapy (1)
- thermal processing (1)
- thermal processing of food (1)
- thermogenesis (1)
- thermoresponsive-nanogel (1)
- thimerosal (1)
- thiol modification (1)
- thiomersal (1)
- thioredoxin-interacting protein (1)
- thymosin beta 4 (1)
- tight junctions (1)
- tissue inhibitior of metalloproteinases 1 (1)
- tocopherol (1)
- topical (1)
- topical drug delivery (1)
- total body fat (1)
- total glycated hemoglobin (1)
- total glycosylated hemoglobin (1)
- total phenol content (1)
- toxicology (1)
- trace element (1)
- trace elements (1)
- training intervention (1)
- trans fatty acids (1)
- trans-Golgi (1)
- trans-migration (1)
- transcription factor (1)
- transferrin-mediated oral delivery (1)
- transformation product (1)
- transforming growth factor beta (1)
- transfusion-related acute lung injury (1)
- transgenerational effects (1)
- transgenes Mausmodell (1)
- transgenic mousemodel (1)
- transient and stable transformation (1)
- transient receptor potential (1)
- transmission of hepatitis B virus (HBV) (1)
- transport proteins (1)
- transthyretin (TTR) (1)
- triazole fungicides (1)
- trypsin inhibitors (1)
- tryptophan quenching (1)
- tumor (1)
- tumor-metastasis (1)
- twin study (1)
- type 2 diabetes (T2DM) (1)
- type II diabetes (T2DM) (1)
- type-2-diabetes (1)
- ubiquitin proteasomal system (1)
- ultra heat treatment (1)
- ultrasound (1)
- umami (1)
- underutilized species (1)
- universal coating (1)
- urban (1)
- urinary biomarker (1)
- urine (1)
- valine (1)
- vascular disease; (1)
- vascular senescence (1)
- vascular smooth muscle cells (1)
- vegan diet (1)
- vending machine (1)
- verzweigtkettige Aminosäuren (1)
- vesicular trafficking (1)
- vesicular transport (1)
- vesikulärer Transport (1)
- veterinary drug (1)
- vitamin (1)
- vitamin A deficiency (1)
- vitamin D binding protein (1)
- vitamin D-binding protein (1)
- vitamin E (1)
- vitamins (1)
- volatile compounds (1)
- weight loss intervention (1)
- weight maintenance (1)
- weight reduction (1)
- weight regulation (1)
- weight status (1)
- western blot (1)
- whey proteins (1)
- white adipose tissue (1)
- whole grains (1)
- whole-grain (1)
- yield enhancement (1)
- yolk (1)
- zeaxanthin (1)
- zentrales Nervensystem (1)
- zinc/iron supplementation (1)
- Östrogene (1)
- Übergewicht (1)
- Übertragung (1)
- ß-Glucan (1)
- ätherische Öle (1)
- α-Tocopheroltransferprotein (Ttpa) (1)
- α-amylase (1)
- α-tocophero (1)
Institute
- Institut für Ernährungswissenschaft (1297) (remove)
Die gesundheitsfördernden Eigenschaften von grünem Tee sind weitgehend akzeptiert. Den Teecatechinen, insbesondere dem Epigallocatechin-3-gallat (EGCG), werden zahlreiche positive Effekte zugesprochen (z. B. antioxidativ, antikanzerogen, antiinflammatorisch, Blutdruck und Cholesterinspiegel senkend). Die Mechanismen, die zu einer Reduktion der in Tierversuchen beschriebenen Körper- und Fettmasse führen, sind nicht ausreichend geklärt. Ziel dieser Arbeit bestand darin, die kurz- und mittelfristigen Wirkungen einer TEAVIGO®-Applikation (mind. 94 % EGCG) am Mausmodell im Hinblick auf den Energie- und Fettstoffwechsel sowie die Expression daran beteiligter Gene in wichtigen Organen und Geweben zu untersuchen. In verschiedenen Tierversuchen wurde männlichen C57BL/6-Mäusen eine Hochfettdiät (HFD) mit und ohne Supplementation (oral, diätetisch) des entkoffeinierten Grüntee-Extraktes TEAVIGO® in unterschiedlichen Dosierungen gefüttert. Es wurden sowohl kurz- als auch mittelfristige Wirkungen des EGCG auf die Energiebilanz (u. a. indirekte Tierkalorimetrie) und Körperzusammensetzung (NMR) sowie die exogene Substratoxidation (Stabilisotopentechnik: Atemtests, Inkorporation natürlicher 13C-angereicherter Triglyceride aus Maiskeimöl in diverse Organe/Gewebe) und Gen-expression (quantitative real-time PCR) untersucht. Die Applikationsform und ihre Dauer riefen unterschiedliche Wirkungen hervor. Mäuse mit diätetischer Supplementation zeigten bereits nach kurzer Zeit eine verminderte Körperfettmasse, die bei weiterer Verabreichung auch zu einer Reduktion der Körpermasse führte. Beide Applikationsformen resultieren, unabhängig von der Dauer der Intervention, in einer erhöhten Energieausscheidung, während die Futter- und Energieaufnahme durch EGCG nicht beeinflusst wurden. Der Energieverlust war von einer erhöhten Fett- und Stickstoffausscheidung begleitet, deren Ursache die in der Literatur beschriebene Interaktion und Hemmung digestiver Enzyme sein könnte. Besonders unter postprandialen Bedingungen wiesen EGCG-Mäuse erniedrigte Triglycerid- und Glycogengehalte in der Leber auf, was auf eine eingeschränkte intestinale Absorption der Nährstoffe hindeutet. Transkriptanalysen ergaben im Darm eine verminderte Expression von Fettsäuretransportern, während die Expression von Glucosetransportern durch EGCG erhöht wurde. Weiterhin reduzierte EGCG, nach Umstellung von Standard- auf eine maiskeimölhaltige Hochfettdiät, die Inkorporation natürlicher 13C-angereicherter Triglyceride in diverse Organe und Gewebe – insbesondere Leber, viszerales und braunes Fettgewebe sowie Skelettmuskel. Die Analyse der 13C-Anreicherung im Atem der Mäuse und die Energieumsatzmessungen ergaben nach kurzer Applikation eine erhöhte Fettoxidation, die im weiteren Verlauf der Intervention auf eine erhöhte Kohlenhydratoxidation umgeschaltet wurde. Weiterhin war die orale Applikation von EGCG bei gleichzeitiger Fütterung einer Hochfettdiät von makroskopischen und mikroskopischen degenerativen Veränderungen der Leber begleitet. Diese Effekte wurden nach diätetischer Supplementation der Hochfettdiät mit EGCG nicht beobachtet. Zusammenfassend zeigen die Ergebnisse, dass die Körpergewichts- und Fettgewebs-abnahme durch diätetisches EGCG sich durch eine herabgesetzte Verdaulichkeit der Nahrung erklären lässt. Dies führte zu verschiedenen kurz- und mittelfristigen Veränderungen in der Fettverteilung und im Fettmetabolismus.
Human anaphylatoxin C3a had previously been shown to increase glycogenolysis in perfused rat liver and prostanoid formation in rat liver macrophages. Surprisingly, human C5a, which in other systems elicited stronger responses than C3a, did not increase glycogenolysis in perfused rat liver. Species incompatibilities within the experimental system had been supposed to be the reason. The current study supports this hypothesis: (1) In rat liver macrophages that had been maintained in primary culture for 72 h recombinant rat anaphylatoxin C5a in concentrations between 0.1 and 10 pg/ml increased the formation of thromboxane A₂, prostaglandin D₂, E₂ and F₂α6- to 12-fold over basal within 10 min. In contrast, human anaphylatoxin C5a did not increase prostanoid formation in rat Kupffer cells. (2) The increase in prostanoid formation by recombinant rat C5a was specific. It was inhibited by a neutralizing monoclonal antibody. (3) In co-cultures of rat hepatocytes and rat Kupffer cells but not in hepatocyte mono-cultures recombinant rat C5a increased glycogen phosphorylase activity 3-fold over basal. This effect was inhibited by incubation of the co-cultures with 500 μM acetylsalicyclic acid. Thus, C5a generated either locally in the liver or systemically e.g. in the course of sepsis, may increase hepatic glycogenolysis by a prostanoid-mediated intercellular communication between Kupffer cells and hepatocytes.
Rat serum, in which the complement sytem had been activated by incubation with zymosan, increased the glucose and lactate output, and reduced and redistributed the flow in isolated perfused rat liver clearly more than the control serum. Heat inactivation of the rat serum prior to zymosan incubation abolished this difference. Metabolic and hemodynamic alterations caused by the activated serum were dose dependent. They were almost completely inhibited by the cyclooxygenase inhibitor indomethacin and by the thromboxane antagonist 4-[2-(4-chlorobenzenesulfonamide)-ethyl]-benzene-acetica cid (BM 13505), but clearly less efficiently by the 5’-lipoxygenase inhibitor nordihydroguaiaretic acid and the leukotriene antagonist N-{3-[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-propoxy]-4-chlorine-6-methyl-phenyl}-1H-tetrazole-5-carboxamide sodium salt (CGP 35949 B). Control serum and to a much larger extent complement-activated serum, caused an overflow of thromboxane B₂ and prostaglandin F₂α into the hepatic vein. It is concluded that the activated complement system of rat serum can influence liver metabolism and hemodynamics via release from nonparenchymal liver cells of thromboxane and prostaglandins, the latter of which can in turn act on the parenchymal cells.
In perfused rat livers, infusion of prostaglandin F₂α (PGF₂α) or noradrenaline increased glucose and lactate output and reduced flow. Glucagon increased glucose output and decreased lactate output without influence on flow. Infusion of phorbol 13-myristate 14-acetate (PMA) for 20 min prior to these stimuli strongly inhibited the metabolic and hemodynamic effects of noradrenaline, reduced the metabolic actions of PGF₂α but did not alter the effects of glucagon. In isolated rat hepatocytes PGF₂α, noradrenaline and glucagon activated glycogen phosphorylase but only PGF₂α and noradrenaline increased intracellular inositol 1,4,5-1risphosphalc (InsP₃). The noradrenaline- or PGF₂α-elicited activation of glycogen phosphorylase and increase in InsP₃ were largely reduced after preincubation of the cells for 10 min with PMA, whereas the glucagon-mediated enzyme activation was not affected. In contra\t to PMA, the phorbol ester 4a-phorbol 13,14-didecanoate. which does not activate protein kinase C, did not attenuate the PGF₂α- and noradrenaline-elicited stimulation of glucose output, glycogen phosphorylase and InsP, formation. Stimulation of InsP₃ formation by AlF₄⁻, which activates phospholipase C independently of the receptor, was not attenuated by prior incubation with PMA. Plasma membranes purified from isolated hepatocytes had both a high-capacity, low-affinity and a low-capacity, high-affinity binding site for PGF₂α. The Kd of the high-capacity, low-affinity binding site was close to the concentration of PGF₂α that increased glycogen phosphorylase activity halfmaximally. Binding to the high-capacity, low-affinity binding site was enhanced by guanosine 5'- 0-(3-thio)triphosphate (GTP[S]). This high-capacity, low-affinity site might thus represent the receptor. The Bmax and Kd of the high-capacity site, as well as the enhancement by GTP[S] of PGF₂α binding to this site, remained unaffected by PMA pretreatment. It is concluded that, in hepatocytes, activation of protein kinase C by PMA interrupted the InsP₃-mediated signal pathway from PGF₂α via a PGF₂α receptor and phospholipase C to glycogen phosphorylase at a point distal of the receptor prior to phospholipase C.
Human placenta is surprisingly rich in post-proline dipeptidyl peptidase activity. Among various cell fractions, microsomes have the highest specific activity. A homogeneous enzyme preparation is obtained in a six-step purification procedure. The final preparation appears homogeneous upon dodecyl sulfate electrophoresis, but analytical isoelectric focussing reveals various active bands with isoelectric points in the range of pH 3 - 4. The enzyme is a glycoprotein containing about 30% carbohydrate. Treatment with neuraminidase lowers the isoelectric points but does not reduce the heterogeneity of the band pattern. The subunit molecular weight is 120000 as estimated by dodecyl sulfate electrophoresis, whereas Mr of the native enzyme is > 200000, as can be concluded from gel filtration experiments. The purified dipeptidyl peptidase cleaves various synthetic and natural peptides, including substance P, kentsin, casomorphin and a synthetic renin inhibitor. In general, the specificity of the placenta peptidase is similar to that of post-proline dipeptidyl peptidase from other sources. Phenylalanylprolyl-P-naphthylamide (Km = 0.02 mM, I/ = 92 Ujmg) is the best substrate among various synthetic peptide derivatives. Only peptides with a free N-terminal amino group and proline, hydroxyproline, or alanine in position 2 of the N-terminal sequence are cieaved. However, X-Pro-Pro- . . . structures, e. g. as in bradykinin, are not attacked. 1 mM bis-(6nitrophenyI)phosphate or 1 mM diisopropylfluorophosphate completely inactivate the peptidase within 30 min at 30°C (pH 8). The peptidase is also completely inhibited by 1 mM Zn²⁺ and by other heavy metals.
Prostaglandin (PG)F₂α has previously been shown to increase glucose output from perfused livers and isolated hepatocytes, where it stimulated glycogen phosphorylase via an inositol-trisphosphatedependent signal pathway. In this study, PGF₂α binding sites on hepatocyte plasma membranes, that might represent the putative receptor, were characterized. Binding studies could not be performed with intact hepatocytes, because PGF₂α accumulated within the cells even at 4°C. The intracellular accumulation was an order of magnitude higher than binding to plasma membranes. Purified hepatocyte plasma membranes had a high-affinity/low-capacity and a low-affinity/highcapacity binding'site for PGF₂α. The respective binding constants for the high-affinity site were Kd = 3 nM and Bmax = 6 fmol/mg membrane protein, and for the low-affinity site Kd = 426 nM and Bmax = 245 fmol/mg membrane protein. Specific PGF₂α binding to the low-affinity site, but not to the high-affinity site, could be enhanced most potently by GTP[γS] followed by GDP[ϐS] and GTP, but not by ATP[γS] or GMP. PGF₂α competed most potently with [³H]PGF₂α for specific binding to hepatocyte plasma membranes, followed by PGD₂ and PGE₂. Since the low-affinity PGF₂α-binding site had a Kd in the concentration range in which PG had previously been shown to be half-maximally active, and since this binding site showed a sensitivity to GTP, it is concluded that it might represent the receptor involved in the PGF₂α signal chain in hepatocytes. A biological function of the high-affinity site is currently not known.
Prostaglandin E₂ has been reported both to stimulate glycogen-phosphorylase activity (glycogenolytic effect) and to inhibit the glucagon-stimulated glycogen-phosphorylase activity (antiglycogenolytic effect) in rat hepatocytes. It was the purpose of this study to resolve this apparent contradiction and to characterize the signalling pathways and receptor subtypes involved in the opposing prostaglandin E₂ actions. Prostaglandin E₂ (10 μM) increased glucose output, glycogen-phosphorylase activity and inositol trisphosphate formation in hepatocyte cell culture andor suspension. In the same systems, prostaglandin E₂ decreased the glucagon-stimulated (1 nM) glycogen-phosphorylase activity and cAMP formation. The signalling pathway leading to the glycogenolytic effect of PGE₂ was interrupted by incubation of the hepatocytes with 4P-phorbol 12-myristate 13-acetate (100 nM) for 10 min, while the antiglycogenolytic effect of prostaglandin E₂ was not attenuated. The signalling pathway leading to the antiglycogenolytic effect of prostaglandin E₂ was interrupted by an incubation of cultured hepatocytes with pertussis toxin (100 ng/ml) for 18 h, whereas the glycogenolytic effect of prostaglandin E₂ was enhanced. The EP₁/EP₃ prostaglandin-E₂-receptor-specific prostaglandin E₂ analogue Sulproston had a stronger glycogenolytic potency than the EP₃ prostaglandin-E₂-receptor-specific prostaglandin E₂ analogue Misoprostol. The antiglycogenolytic potency of both agonists was equal. It is concluded that the glycogenolytic and the antiglycogenolytic effects of prostaglandin E₂ are mediated via different signalling pathways in hepatocytes possibly involving EP₁ and EP₃ prostaglandin E₂ receptors, respectively.
In the isolated rat liver perfused in situ, stimulation of the nerve bundles around the hepatic artery and portal vein caused an increase of glucose and lactate output and a reduction of perfusion flow. These changes could be inhibited completely by α-receptor blockers. The possible involvement of inositol phosphates in the intracellular signal transmission was studied. 1. In cell-suspension experiments, which were performed as a positive control, noradrenaline caused an increase in glucose output and, in the presence of 10 mM LiCl, a dose-dependent and time-dependent increase of inositol mono, bis and trisphosphate. 2. In the perfused rat liver 1 μM noradrenaline caused an increase of glucose and lactate output and in the presence of 10 mM LiCl a time-dependent increase of inositol mono, bis and trisphosphate that was comparable to that observed in cell suspensions. 3. In the perfused rat liver stimulation of the nerve bundles around the portal vein and hepatic artery caused a similar increase in glucose and lactate output to that produced by noradrenaline, but in the presence of 10 mM LiCl there was a smaller increase of inositol monophosphate and no increase of inositol bis and trisphosphate. These findings are in line with the proposal that circulating noradrenaline reaches every hepatocyte, causing a clear overall increase of inositol phosphate formation and thus calcium release from the endoplasmic reticulum, while the hepatic nerves reach only a few cells causing there a small local change of inositol phosphate metabolism and thence a propagation of the signal via gap junctions.
Rat hepatocytes have previously been reported to possess prostaglandin E₂ receptors of the EP₃-type (EP₃-receptors) that inhibit glucagonstimulated glycogenolysis by decreasing cAMP. Here, the isolation of a functional EP₃ϐ receptor cDNA clone from a rat hepatocyte cDNA library is reported. This clone can be translated into a 362-amino-acid protein, that displays over 95% homology to the EP₃ϐ receptor from mouse mastocytoma. The amino- and carboxy-terminal region of the protein are least conserved. Transiently transfected HEK 293 cells expressed a single binding site for PGE₂ with an apparent Kd of 15 nM. PGE₂ > PGF₂α > PGD₂ competed for [³H]PGE₂ binding sites as did the EP₃ receptor agonists M&B 28767 = sulprostone > misoprostol but not the EP₁ receptor antagonist SC 19220. In stably transfected CHO cells M&B 28767 > sulprostone = PGE₂ > misoprostol > PGF₂α inhibited the forskolin-elicited cAMP formation. Thus, the characteristics of the EP₃ϐ receptor of rat hepatocytes closely resemble those of the EP₃ϐ receptor of mouse mastocytoma.
In cultured rat hepatocytes the key gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PCK) is known to be induced by glucagon via an elevation of cAMP. Prostaglandin E₂ has been shown to antagonize the glucagon-activated cAMP formation, glycogen phosphorylase activity and glucose output in hepatocytes. It was the purpose of the current investigation to study the potential of PGE₂ to inhibit the glucagon-induced expression of PCK on the level of mRNA and enzyme activity. PCK mRNA and enzyme activity were increased by 0.1 nM glucagon to a maximum after 2 h and 4 h, respectively. This increase was completely inhibited if 10 μM PGE2 was added concomitantly with glucagon. This inhibition by PGE₂ of glucagon-induced PCK activity was abolished by pertussis toxin treatment. When added at the maximum of PCK mRNA at 2 h, PGE₂ accelerated the decay of mRNA and reduced enzyme activity. This effect was not reversed by pertussis toxin treatment. Since in liver PGE₂ is derived from Kupffer cells, which play a key role in the local inflammatory response, the present data imply that during inflammation PGE₂ may reduce the hepatic gluconeogenic capacity via a Gᵢ-linked signal chain.
Background: Very recently a gene marker panel that allows the mutational analysis of APC, CTNNB1, B-RAF and K-RAS was conceived. The aim of the present study was to use the 4-gene marker panel covering the Wnt and Ras-Raf-MEK-MAPK signalling pathways to determine the percentage of sporadic colorectal carcinomas (CRC) carrying at least one of the four above-mentioned genes in a mutated form alone and/or in combination with microsatellite instability (MSI) and to compare the sensitivity of the gene marker panel used in this study with that of gene marker panels previously reported in the scientific literature. Methods: CTNNB1 and B-RAF were screened by PCR-single-strand conformation polymorphism analysis and K-RAS gene mutations by restriction fragment length polymorphism analysis. For the mutational analysis of the APC gene mutation cluster region (codons 1243–1567) direct DNA sequencing was performed. The U.S. National Cancer Institute microsatellite panel (BAT25, BAT26, D2S123, D5S346 and D17S250) was used for MSI analysis. Results: It could be shown that about 80% of early stage CRC (UICC stages I and II) and over 90% of CRC in the UICC stage IV carried at least one mutated gene and/or showed MSI. No significant increase in the gene mutation frequencies could be determined when comparing tumours in the UICC stage I with those in UICC stage IV. Conclusions: When compared with previously published gene marker panels the 4-gene marker panel used in the present study shows an excellent performance, allowing to detect genetic alterations in 80–90% of human sporadic CRC samples analyzed.
Heterocyclic aromatic amines (HCAs) are formed in meat cooked at high temperatures for a long time or over an open flame. In this context 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant HCA in cooked meat, has been suggested to be involved in colon and prostate carcinogenesis. In the latter case it has been reported that: (1) roughly 50% of Fischer F344 male rats treated with PhIP develop carcinomas in the ventral prostate lobe at 1 year of age; (2) inflammation precedes prostatic intraepithelial neoplasia in PhIP-fed rats; (3) inflammation specifically occurs in the ventral prostate lobe of PhIP-fed rats. To test whether PhIP by itself leads to inflammation in the colon and whether a human-relevant concentration of PhIP is able to induce preneoplastic lesions in the colon, male F344 rats were fed 0.1 or 100 ppm PhIP for up to 10 months and thereafter the colon tissue was analyzed histochemically. In none of the experimental groups signs of acute or chronic colonic inflammation were observed. 0.1 ppm PhIP leads to the development of hyperplastic and dysplastic lesions in the colon of single animals, but the incidence of these lesions does not reach a statistical significance. In contrast, in rats fed 100 ppm PhIP for 10 months hyperplastic and dysplastic colonic lesions were induced in a statistically significant number of animals. It is concluded that: (1) the induction of preneoplastic lesions in rat colon by PhIP is not preceded or accompanied by an inflammatory process; (2) a human-relevant concentration of PhIP alone is not sufficient to initiate colon carcinogenesis in rats.
Eine besondere Rolle im Fremdstoffmetabolismus hat die SULT1A1 beim Menschen aufgrund der hohen Expression und breiten Gewebeverteilung. Während die humane SULT1A1 in sehr vielen Geweben exprimiert wird, wurde die murine SULT1A1 vor allem in der Leber, Lunge und Colon gefunden. Neben der Gewebeverteilung spielt auch der Polymorphismus im humanen SULT1A1-Gen eine bedeutende Rolle. Der häufigste Polymorphismus in diesem Gen führt zu einer Aminosäuresubstitution von Arginin zu Histidin an Position 213. Die Genvariante mit Histidin (auch als SULT1A1*2 bezeichnet) codiert für ein Protein mit einer geringen Enzymaktivität und einer reduzierten Enzymmenge in Thrombocyten. Über den Einfluss dieser allelischen Varianten in anderen Geweben ist bislang wenig bekannt. In vorausgegangenen epidemiologischen Studien wurden mögliche Korrelationen zwischen den Genvarianten und der Krebsentstehung in verschiedenen Geweben untersucht. Diese Daten liefern jedoch widersprüchliche Ergebnisse zum Krebsrisiko. Aufgrund der strittigen epidemiologischen Daten sollten Tiermodelle generiert werden, um die häufigsten SULT1A1-Allele hinsichtlich der Empfindlichkeit gegenüber Nahrungs- und Umweltkanzerogenen zu untersuchen. Zur Erzeugung transgener (tg) Mauslinien wurde mittels Mikroinjektion der codierenden Genbereich und große flankierende Humansequenzen stromaufwärts und stromabwärts in das Mausgenom integriert. Es wurden mehrere Mauslinien hergestellt. Zwei davon, die Mauslinie 31 mit dem SULT1A1*1-Allel und die Mauslinie 28 mit dem SULT1A1*2-Allel, wurden eingehend analysiert. In beiden Linien wurde eine identische Kopienzahl des Transgens ermittelt. Proteinbiochemische Charakterisierungen zeigten eine weitgehend dem Menschen entsprechende Gewebeverteilung und zelluläre und subzelluläre Lokalisation der humanen SULT1A1 in der Linie (Li) 28. In Li 31 wurden Unterschiede zu Li 28 sowohl in der Gewebeverteilung als auch in der zellulären Lokalisation des exprimierten humanen Proteins ermittelt. Dabei war die Expression auf Proteinebene in der SULT1A1*2-tg Linie generell stärker als in der SULT1A1*1-Linie. Dieses Ergebnis war überraschend, denn in humanen Thrombocyten führt das SULT1A1*1-Allel zu einem höheren Gehalt an SULT1A1-Protein als das SULT1A1*2-Allel. Zur Analyse der unterschiedlichen Proteinexpressionen in den tg Mauslinien wurde die cDNA und der 5´-flankierende Bereich des SULT1A1-Gens sequenziert. In beiden tg Linien entsprach die Sequenz der cDNA der Referenzsequenz aus der Gendatenbank (Pubmed). In der 5´-flankierenden Region wurden bekannte Polymorphismen analysiert und unterschiedliche Haplotypen in den tg Linien an den Positionen -624 und -396 ermittelt. Dabei wurde in der Li 31 der Haplotyp detektiert, der in der Literatur mit einer höheren SULT1A1-Enzymaktivität beschrieben wird. Der mögliche Zusammenhang zwischen Transkriptionsrate und Proteinexpression wurde in RNA-Expressionsanalysen im codierenden und 5´-nicht codierenden Bereich (mit den alternativen Exons 1B und 1A) untersucht. Im codierenden Bereich und im Exon 1B konnte in den untersuchten Organen eine höhere RNA-Expression in der Li 28 im Vergleich zur Li 31 ermittelt werden. Außer in der Lunge wurde für Exon 1B eine identische RNA-Expression detektiert. RNA, die Exon 1A enthielt, wurde in allen untersuchten Organen der Li 28, aber nur in der Lunge bei der Li 31 gefunden. In beiden tg Linien konnten mit den Exon 1A-Primern jedoch auch größere PCR-Produkte ermittelt werden. Dieser Unterschied im Exon 1A und mögliche Spleißvarianten könnten damit für die unterschiedliche Proteinexpression des humanen SULT1A1-Proteins in den beiden tg Mauslinien sein. Die in dieser Arbeit generierten und charakterisierten tg Mausmodelle wurden in einer toxikologischen Studie eingesetzt. Es wurde das heterozyklische aromatische Amin 2-Amino-1-methyl-6-phenylimidazo-[4,5-b]pyridin (PhIP) verwendet. PhIP wird beim Erhitzen und Braten von Fleisch und Fisch gebildet und könnte mit der erhöhten Krebsentstehung im Colon in der westlichen Welt im Zusammenhang stehen. Mittels 32P-Postlabelling sollte der Einfluss der zusätzlichen Expression der humanen SULT-Proteine auf die PhIP-DNA-Adduktbildung analysiert werden. Dabei wurden mehr DNA-Addukte in den tg Tieren als in den Wildtyp-Mäusen ermittelt. Die Konzentration der gebildeten DNA-Addukte korrelierte mit der Expressionsstärke des humanen SULT1A1-Proteins in den tg Mäusen. An den in dieser Arbeit generierten tg Mauslinien mit den häufigsten allelischen Varianten des SULT1A1-Gens konnten Unterschiede auf RNA- und Protein-Ebene ermittelt werden. Zudem konnte gezeigt werden, dass die Expression der humanen SULT1A1 eine Auswirkung sowohl auf die Stärke als auch das Zielgewebe der DNA-Adduktbildung in vivo hat.
Der ubiquitär exprimierte, multifunktionale Glucosetransporter GLUT8 gehört zur Klasse III der Familie der passiven Glucosetransporter, die aus insgesamt 14 Proteinen besteht. Die fünf Mitglieder der Klasse IIII unterscheiden sich strukturell leicht von den Mitgliedern der Klasse I und II (Joost und Thorens, 2001). GLUT8 besitzt ein N-terminales Dileucin-Motiv, das Teil eines [DE]XXXL[LI] Motivs ist, welches für die Sortierung des Transporters in späte Endosomen und Lysosomen verantwortlich ist (Augustin et al., 2005). Da bis heute kein Signal identifiziert wurde, das eine Translokation des Transporters zur Plasmamembran auslöst, wird eine intrazelluläre Funktion von GLUT8 vermutet (Widmer et al., 2005). Im Rahmen der vorliegenden Arbeit wurde die intrazelluläre Funktion des Transporters in der Regulation der Glucosehomöostase des Körpers durch Analyse einer Slc2a8-knockout-Maus untersucht. Die homozygote Deletion des Transporters erbrachte lebensfähige Nachkommen, die sich augenscheinlich nicht von ihren Wildtyp-Geschwistern unterschieden. Allerdings wurde bei Verpaarungen heterozygoter Mäuse eine verminderte Anzahl an Slc2a8-/--Nachkommen beobachtet, die signifikant von der erwarteten Mendel’schen Verteilung abwich. Da Slc2a8 die höchste mRNA-Expression in den Testes aufwies und die Überprüfung der Fertilität mittels verschiedener homozygoter Verpaarungen eine Störung der weiblichen Fortpflanzungsfähigkeit ausschloss, wurden die Spermatozoen der Slc2a8-/--Mäuse eingehender untersucht. Als Ursache für die verringerte Anzahl von Slc2a8-/--Geburten wurde eine verminderte Prozentzahl motiler Slc2a8-/--Spermien ermittelt, die durch eine unzureichende mitochondriale Kondensation in den Spermien bedingt war. Diese Veränderung war mit einem reduzierten mitochondrialen Membranpotential assoziiert, was eine verminderte ATP-Produktion nach sich zog. Somit scheint GLUT8 in den Spermien an einem intrazellulären Transportprozess beteiligt zu sein, der einen Einfluss auf die oxidative Phosphorylierung der Mitochondrien ausübt. Im Gehirn wurde Slc2a8 besonders stark im Hippocampus exprimiert, der in der Regulation von körperlicher Aktivität, Explorationsverhalten, Erinnerungs- und Lernprozessen sowie Angst- und Stressreaktionen eine Rolle spielt. Außerdem wurde GLUT8 im Hypothalamus nachgewiesen, der unter anderem an der Regulation der Nahrungsaufnahme beteiligt ist. Die Slc2a8-/--Mäuse zeigten im Vergleich zu ihren Slc2a8+/+-Geschwistern eine signifikant gesteigerte körperliche Aktivität, die zusammen mit der von Membrez et al. (2006) publizierten erhöhten Zellproliferation im Hippocampus auf eine Nährstoffunterversorgung dieses Areals hindeutet. Die Nahrungsaufnahme war in Abwesenheit von GLUT8 nicht verändert, was zusammen mit dem nur geringfügig niedrigeren Körpergewicht der Slc2a8-/--Mäuse eine Funktion von GLUT8 im Glucose-sensing der Glucose-sensitiven Neurone des Gehirns ausschließt. Das leicht reduzierte Körpergewicht der Slc2a8-/--Mäuse ließ sich keinem bestimmten Organ- oder Gewebetyp zuordnen, sondern schien durch eine marginale Gewichtsreduktion aller untersuchten Gewebe bedingt zu sein. Zusammen mit den erniedrigten Blutglucosespiegeln und der anscheinend gesteigerten Lebenserwartung zeigten die Slc2a8-/--Mäuse Symptome einer leichten Nährstoffunterversorgung. GLUT8 scheint daher am Transport von Zuckerderivaten, die während des lysosomalen/endosomalen Abbaus von Glykoproteinen anfallen, beteiligt zu sein. Die so wiederaufbereiteten Zucker dienen dem Körper offenbar als zusätzliche Energiequelle.
Vitamin E wird immer noch als das wichtigste lipophile Antioxidanz in biologischen Membranen betrachtet. In den letzten Jahren hat sich jedoch der Schwerpunkt der Vitamin E-Forschung hin zu den nicht-antioxidativen Funktionen verlagert. Besonderes Interesse gilt dabei dem α-Tocopherol, der häufigsten Vitamin E-Form im Gewebe von Säugetieren, und seiner Rolle bei der Regulation der Genexpression. Das Ziel dieser Dissertation war die Untersuchung der genregulatorischen Funktionen von α-Tocoperol und die Identifizierung α-Tocopherol-sensitiver Gene in vivo. Zu diesem Zweck wurden Mäuse mit verschiedenen Mengen α-Tocopherol gefüttert. Die Analyse der hepatischen Genexpression mit Hilfe von DNA-Microarrays identifizierte 387 α-Tocopherol-sensitive Gene. Funktionelle Clusteranalysen der differentiell exprimierten Gene zeigten einen Einfluss von α-Tocooherol auf zelluläre Transportprozesse. Besonders solche Gene, die an vesikulären Transportvorgängen beteiligt sind, wurden größtenteils durch α-Tocopherol hochreguliert. Für Syntaxin 1C, Vesicle-associated membrane protein 1, N-ethylmaleimide-sensitive factor and Syntaxin binding protein 1 konnte eine erhöhte Expression mittels real time PCR bestätigt werden. Ein funktioneller Einfluss von α-Tocopherol auf vesikuläre Transportprozesse konnte mit Hilfe des in vitro β-Hexosaminidase Assays in der sekretorischen Mastzelllinie RBL-2H3 gezeigt werden. Die Inkubation der Zellen mit α-Tocopherol resultierte in einer konzentrationsabhängigen Erhöhung der PMA/Ionomycin-stimulierten Sekretion der β-Hexosaminidase. Eine erhöhte Expression ausgewählter Gene, die an der Degranulation beteiligt sind, konnte nicht beobachtet werden. Damit schien ein direkter genregulatorischer Effekt von α-Tocopherol eher unwahrscheinlich. Da eine erhöhte Sekretion auch mit β-Tocopherol aber nicht mit Trolox, einem hydrophilen Vitamin E-Analogon, gefunden wurde, wurde vermutet, dass α-Tocopherol die Degranulation möglicherweise durch seine membranständige Lokalisation beeinflussen könnte. Die Inkubation der Zellen mit α-Tocopherol resultierte in einer veränderten Verteilung des Gangliosids GM1, einem Lipid raft Marker. Es wird angenommen, dass diese Membranmikrodomänen als Plattformen für Signaltransduktionsvorgänge fungieren. Ein möglicher Einfluss von Vitamin E auf die Rekrutierung/Translokation von Signalproteinen in Membranmikrodomänen könnte die beobachteten Effekte erklären. Eine Rolle von α-Tocopherol im vesikulären Transport könnte nicht nur seine eigene Absorption und seinen Transport beeinflussen, sondern auch eine Erklärung für die bei schwerer Vitamin E-Defizienz auftretenden neuronalen Dysfunktionen bieten. Im zweiten Teil der Arbeit wurde die α-Tocopheroltransferprotein (Ttpa) Knockout-Maus als genetisches Modell für Vitamin E-Defizienz verwendet, um den Effekt von Ttpa auf die Genexpression und die Gewebeverteilung von α-Tocopherol zu analysieren. Ttpa ist ein cytosolisches Protein, das für die selektive Retention von α-Tocopherol in der Leber verantwortlich ist. Die Ttpa-Defizienz resultierte in sehr geringen α-Tocopherol-Konzentrationen im Plasma und den extrahepatischen Geweben. Die Analyse der α-Tocopherol-Gehalte im Gehirn wies auf eine Rolle von Ttpa bei der α-Tocopherol-Aufnahme ins Gehirn hin.
Untersuchung des Recyclings Kaede-fusionierter Corticotropin-Releasing-Factor Rezeptoren Typ 1
(2009)
Aktivierte G-Protein-gekoppelte Rezeptoren (GPCR) werden schnell desensitisiert, internalisiert und anschließend entweder lysosomal degradiert oder zur Plasmamembran (PM) recycelt. Zur Resensitisierung der Zellen tragen neben recycelten auch neusynthetisierte Rezeptoren bei. Die Überlagerung beider Prozesse erschwert die Untersuchung des Rezeptorrecyclings. In dieser Arbeit sollte mit Hilfe des photokonvertierbaren Fluoreszenzproteins Kaede eine Technik entwickelt werden, mit der es möglich ist Recycling- von Neusyntheseprozessen zu trennen und das Recycling von GPCR mikroskopisch in Echtzeit zu beobachten. Als Modellproteine wurden der Vasopressin-1a-Rezeptor V1aR (recycelnder Rezeptor), der Vasopressin-2-Rezeptor V2R (degradierter Rezeptor) und der Corticotropin-Releasing Factor-Rezeptor Typ 1 (CRF1R) verwendet, wobei bei Letzterem untersucht werden sollte, ob er nach Stimulation zur PM zurücktransportiert wird. Da Kaede als fluoreszierendes Protein mit den GPCR fusioniert wird, wurde zunächst überprüft, ob es die Eigenschaften der Rezeptoren verändert und generell für Transportstudien geeignet ist. Eventuell könnte die bereits publizierte Tetramerisierung von Kaede seine Anwendung verhindern oder erschweren. Mittels Fluoreszenz-Korrelationsspektroskopie konnte gezeigt werden, dass Kaede nicht tetramerisiert, wenn es an ein Membranprotein fusioniert ist. Außerdem konnte in in vitro- und Zellkulturexperimenten belegt werden, dass die native und die photokonvertierte Form von Kaede gleichermaßen stabil sind. Darüber hinaus zeigten Kaede-fusionierte GPCR sowohl in Kolokalisationsstudien als auch in Agonistbindungs- und Rezeptoraktivierungsexperimenten die gleichen Eigenschaften wie CFP- bzw. die unfusionierte Rezeptoren. Lediglich die Expression der Kaede-fusionierten Rezeptoren war geringer. Parallel wurde anhand der bereits publizierten Kaede-Struktur versucht, die Tetramerisierung des Proteins durch den Austausch interagierender Aminosäuren zu unterbinden. Die eingeführten Mutationen bewirkten aber eine Fehlfaltung des Proteins und damit den Verlust der Fluoreszenz. Da zuvor gezeigt werden konnte, dass Kaede-fusionierte Membranproteine nicht tetramerisieren und nicht die Eigenschaften der fusionierten Proteine verändern, war monomerisiertes Kaede zur Untersuchung des Rezeptorrecyclings nicht notwendig. Im zweiten Teil der Arbeit wurde mit Hilfe von Kaede-Fusionsproteinen und mikroskopischer Testsysteme das noch unbekannte Recyclingverhalten des CRF1R untersucht. Hierfür wurden die Kaede-fusionierten Rezeptoren in eukaryotischen Zellen exprimiert und mit Agonisten internalisiert. Die internalisierten Rezeptoren wurden in Endosomen selektiv mit UV-Strahlung photokonvertiert. Anschließend wurde der Transport der photokonvertierten Form verfolgt. Sowohl beim CRF1R als auch beim V1aR wurden Signale in der PM detektiert, beim V2R hingegen nicht. Dies zeigt, dass es sich beim CRF1R um einen recycelnden Rezeptor handelt. Die als Kontrolle eingesetzten Rezeptoren verhielten sich in diesem Experiment wie erwartet: Der V1aR wurde zur PM zurücktransportiert, der V2R nicht. Diese Ergebnisse konnten mit Hilfe biochemischer und durchflusscytometrischer Experimente bestätigt werden. Die Internalisierung des CRF1R verläuft Clathrin-vermittelt in Anwesenheit von β-Arrestin. Je nach Stabilität der β Arrestin-Interaktion unterscheidet man zwei Klassen von Rezeptoren: Klasse A-Rezeptoren interagieren transient mit β Arrestin und können recyceln. Im Gegensatz dazu gehen Klasse B-Rezeptoren eine stabile Interaktion mit β Arrestin ein und werden nach Internalisierung degradiert. In mikroskopischen Untersuchungen konnte für die aktivierten CRF1R und V1aR eine Rekrutierung von β Arrestin zur PM und eine transiente Interaktion mit β Arrestin gezeigt werden (Klasse A-Rezeptoren). Für den V2R wurde dagegen eine stabile Interaktion mit β Arrestin beobachtet (Klasse B-Rezeptor). Diese Daten stützen die Ergebnisse des Kaede-basierten Recyclingversuchs und zeigen, dass der CRF1R ein recycelnder Rezeptor ist. Ferner wurde untersucht, ob der CRF1R zu den schnell oder langsam recycelnden Rezeptoren zählt. Schnell recycelnde Rezeptoren werden direkt aus frühen Endosomen, langsam recycelnde hingegen über das Trans-Golgi-Netzwerk (TGN) bzw. über Recycling-Endosomen zur PM transportiert. Als Marker für das TGN oder die Recycling-Endosomen wurde Rab11 verwendet. In Kolokalisationsstudien konnte gezeigt werden, dass der CRF1R den langsam recycelnden Rezeptoren zugeordnet werden kann. Zusammenfassend konnte in dieser Arbeit belegt werden, dass Kaede als Fusionspartner für Membranproteine genutzt werden kann um deren Transport in Echtzeit zu studieren. Damit wurde erstmals eine mikroskopische Methode etabliert, die es erlaubt recycelnde von neusynthetisierten Rezeptoren zu unterscheiden. Mit Hilfe dieser Methode war es möglich zu zeigen, dass der CRF1R ein recycelnder Rezeptor ist.
Die Induktion antioxidativer Enzyme gilt als eine Möglichkeit, die antioxidative Kapazität von Zellen zu steigern und dadurch mit oxidativem Stress assoziierten Erkrankungen (z. B. Herz-Kreislauf-Erkrankungen, Neurodegeneration, Atherosklerose) vorzubeugen. Ausgehend davon wurde in der vorliegenden Arbeit der Dual-Luciferase-Reportergen-(DLR)-Assay zum Nachweis der Induktion der antioxidativen Enzyme Katalase (CAT), zytosolische Glutathion-Peroxidase (GPX1) und Kupfer-Zink-Superoxid-Dismutase (SOD1) entwickelt. Im Zuge dessen wurden drei Säugetierzelllinien (CaCo2, IEC-18, V79) auf ihre Eignung zur Modellzelllinie untersucht. Aufgrund der Transfektionseffizienz wurde die Fibroblastenzelllinie V79 ausgewählt. Zur Gewährleistung eines hohen Substanzdurchsatzes des DLR-Assays wurden bei der Etablierung Parameter wie Kulturplattenformat, DNA-Menge, Luciferasen-Kinetik berücksichtigt. Nach erfolgreicher Etablierung des Versuchs im 96-Well-Format wurden L-Carnitin, Catechin, Epigallocatechingallat, Genistein, Wasserstoffperoxid (H2O2), Natrium-Ascorbat, Paraquat, Quercetin, 12-O-Tetradecanoylphorbol-13-Acetat (TPA) und Trolox in nicht-zytotoxischen Konzentrationen hinsichtlich der Aktivierung des Ratten-CAT-, des humanen GPX1- und des humanen SOD1-Promotors untersucht. Die Bestimmung der maximal tolerierbaren Behandlungskonzentration erfolgte im Vorfeld mittels Resazurintest. Von den zehn Verbindungen zeichneten sich drei Substanzen als potente Induktoren für die SOD1 und die GPX1 aus. Die 24-stündige Behandlung von mit Reportergenkonstrukten transient transfizierten V79-Zellen mit 100 µM Paraquat resultierte in einer Verdopplung der relativen SOD1-Promotor-Aktivität und einer Erhöhung der relativen GPX1-Promotor-Aktivität auf 1,6 bzw. 1,7. Die Stimulation mit 20 µM Genistein oder 10 µM Quercetin führte wiederum zu einer Verdopplung bis Verdreifachung der relativen SOD1- und GPX1-Promotor-Aktivität. Der Promotor der Rattenkatalase konnte demgegenüber nur durch 50 µM H2O2 aktiviert werden (1,5fach). Für diesen DLR-Assays bieten sich folglich Genistein, Quercetin wie auch H2O2 als Referenzsubstanzen an. Um aber eine qualitative Charakterisierung der einzelnen Verbindungen hinsichtlich ihres Induktionspotentials zu gewährleisten, sollten von allen getesteten Substanzen Dosis-Wirkungskurven aufgenommen werden. Zudem wird für den routinemäßigen Einsatz die Verwendung stabil transfizierter Zellen zur Vermeidung von mit der Transfektion verbundenen experimentellen Schwankungen empfohlen.
Dietary antioxidants are believed to play an important role in the prevention and treatment of a variety of diseases associated with oxidative stress. Although there is a wide range of dietary antioxidants, the bulk of the research to date has been focused on the nutrient antioxidants vitamin C, E, and carotenoids. Certain relatively uncommon antioxidants such as lipoic acid (LA), and phenolic compounds such as (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin gallate (EGCG), have not been extensively investigated although they may exert greater antioxidant potency than that of carotenoids and vitamins. Extracts from selected plants and plant byproducts may represent rich sources for one or more of such antioxidants and therefore exhibit higher effects than a single antioxidant due to the synergistic effects produced between such antioxidants. However, in the last decade a number of epidemiological, animal and in vitro studies have suggested a protective and therapeutic potency of these antioxidants in a broad range of diseases such as cancer, diabetes, atherosclerosis, cataract and acute and chronic neurological disorders. Inflammation, the response of the host toward any infection or injury, plays a central role in the development of many chronic diseases. Several evidences demonstrated the rise of different types of cancer from sites of inflammation. This suggests that active oxygen species and some cytokines generated in the inflamed tissues can cause injury to DNA and ultimately lead to carcinogenesis. Diethylnitrosamine (DEN) is one of the most important environmental carcinogens, present in a variety of foods, alcoholic beverages, tobacco smoke and it can be synthesized endogenously. In addition to the liver it can induce carcinogenesis in other organs like kidney, trachea, lung, esophagus, fore stomach, and nasal cavity. Several epidemiological and laboratory studies indicate that nitroso compounds including DEN may induce hyperplasia and chronic inflammation which is closely associated with the development of hepatocellular carcinoma. Despite increasing evidence on the potential of antioxidants in modulating the etiology of chronic diseases, little is known about their role in inflammation and acute phase response (APR). Therefore the aim of the present work was to study the protective effect of water and solvent extracts of eight plant and plant byproducts including green tea, artichoke, spinach, broccoli, onion and eggplant, orange and potato peels as well as eight antioxidants agents including EC, EGC, ECG, EGCG, ascorbic acid (AA), acetylcysteine (NAC), α-LA, and alpha-tocopherol (α-TOC) toward acute inflammation induced by interleukin-6 (IL-6) and hepatotoxicity induced by DEN in vitro. The negative acute phase proteins (APP), transthyretin (TTR) and retinol-binding protein (RBP) were used as inflammatory biomarkers analyzed by ELISA, whereas neutral red assay was used for evaluating the cytotoxicity. All experiments were performed in vitro using human hepatocarcinoma cell line (HepG2). Additionally the antioxidant activity was measured by TEAC and FRAP assays, phenolic content was measured by Folin–Ciocalteu and characterized by HPLC. Moreover, the microheterogeneity of TTR was detected using immunoprecipitation assay combined with SELDI-TOF MS. Results of present study showed that HepG2 cells provide a simple, sensitive in vitro system for studying the regulation of the negative APP, TTR and RBP under free and inflammatory condition. IL-6, a potent proinflammatory cytokine, in a concentration of 25 ng/ml was able to reduce TTR and RBP secretion by approximately 50-60% after 24h of incubation. With exception of broccoli and water extract of onion which showed pro-inflammatory effects in this study, all other plant extracts, at specific concentrations, were able to elevate TTR secretion in normal condition and even under treatment of IL-6 where the effect was quite lower. Green tea followed by artichoke and potato peel exhibited the highest elevation in TTR concentration which reached 1.1 and 2.5 folds of control in presence and absences of IL-6 respectively. In general Plant extracts were ordered according their anti-inflammatory potency as following: in water extracts; green tea > artichoke > potato peel > orange peel > spinach > eggplant peel, where in solvent extracts; green tea > artichoke > potato peel > spinach > eggplant peel > onion > orange peel. The antiinflammatory effect of water extracts of green tea, artichoke and orange peel were significantly higher than their corresponding solvent extracts whereas water extracts of eggplant-, potato peels and spinach showed lower effect than their solvent extracts. On the other hand α-LA followed by EGCG and ECG exhibited the highest elevation in TTR concentration compared to other antioxidants. The relation between the anti-inflammatory potential and antioxidants activity and phenolic content for the investigated substances was generally weak. This may suggest the involvement of other mechanisms than antioxidants properties for the observed effect. TTR secreted by HepG2 cells has a molecular structure quite similar to the purified standard and serum TTR in which all the three main variants are contained including native, S-cystinylated and Sglutathionylated TTR. Interestingly, a variant with molecular mass of 13453.8 + 8.3 Da has been detected only in TTR secreted by HepG2. Among all investigated antioxidants and plant extracts, six substances were able to elevate the native preferable TTR variant. The potency of these substances can be ordered as following α-LA > NAC > onion > AA > EGCG > green tea. A weak correlation between elevation on TTR and shifting to the native form was observed. Similar weak correlation has also been observed between antioxidants activity and elevation in native TTR. Although DEN was able to induce cell death in a concentration dependent manner, it requires considerably higher concentrations for its effects especially after 24h. This may be attributed to a lack in cytochrome P450 enzymes produced by HepG2. At selected concentrations some antioxidants and plant extracts significantly attenuate DEN cytotoxicity as following: spinach > α-LA > artichoke > orange peel > eggplant peel > α-TOC > onion > AA. Contrary all other substances especially green tea, broccoli, potato peel, and ECG stimulate DEN toxicity. In conclusion, this study demonstrated that selected antioxidants and plant extracts may attenuate the inflammatory process, not only by their antioxidants potency but also by other mechanisms which remain unclear. They may also play a vital role on stabilizing the tetramic structure of TTR and thereby prevent amyloidosis diseases. Lipoic acid represents in this study unique function against inflammation and hepatotoxicity. Despite the protective effect demonstrated by investigated substances, attention should also be given to the pro-oxidant and potential cytotoxic effects produced at higher concentrations.
Die funktionelle Bedeutung des Coxsackie- und Adenovirus Rezeptors (CAR) im kolorektalen Karzinom
(2009)
Der Coxsackie- und Adenovirus Rezeptor (CAR) ist als Bestandteil von Tight Junctions (TJ) an interzellulären Adhäsionsprozessen beteiligt und scheint eine wichtige Rolle in der Karzinogenese zu spielen. Diese ist jedoch insbesondere bei Entstehung von Darmkrebs weitgehend unklar. Ziel der Arbeit war es daher, die funktionelle Bedeutung, mögliche Interaktionspartner sowie die Expressionsregulation von CAR im kolorektalen Karzinom zu analysieren. In den Zelllinien CaCo2, Colo205, DLD1, HCT116, HT29, SW480 und T84 konnte die Expression von CAR (mRNA und Protein) nachgewiesen werden. Nach stabiler CAR-Überexpression durch Transfektion von CARcDNA in DLD1, HCT116 und SW480 wurde das Zellwachstum gehemmt und eine Abnahme von Migration und Invasion induziert. Eine stabile CAR-Inhibition nach Transfektion von CARsiRNA führte in diesen Zelllinien zum Anstieg der Proliferation sowie zu verstärkter Migrations- und Invasionsaktivität, die in DLD1 mit morphologischen Änderungen einhergingen. Eine Genexpressionsanalyse der Zelllinie DLD1 mit CAR-Inhibition identifizierte α-Catenin als das am stärksten regulierte Gen. Obwohl keine direkte Interaktion beider Proteine detektiert werden konnte, führte eine stabile Re-Expression von α-Catenin in DLD1 mit stabiler CAR-Inhibition zu einer deutlichen Reduktion von Proliferation, Migration und Invasion sowie zu einem Rückgang der zellmorphologischen Änderungen. Um den Einfluss von Differenzierung auf die Regulation der CAR-Expression zu untersuchen, erfolgte eine Behandlung aller Zelllinien mit Natriumbutyrat. Dies führte in fünf der sieben Zelllinien zu einer Aktivierung des CAR-Promotors sowie zu einer gesteigerten Expression und Immunoreaktivität von CAR an der Zelloberfläche. Die Zelllinie CaCo2 zeigte nach spontaner Differenzierung durch 21-tägiges Wachstum post Konfluenz ebenfalls eine verstärkte CAR-mRNA-Expression sowie eine erhöhte CAR-Präsenz an der Zelloberfläche. Die gewonnenen Daten konnten die funktionelle Bedeutung von CAR für die Kolonkarzinogenese sowie den Einfluss von α-Catenin auf diese Funktion deutlich machen. Es wurde gezeigt, dass die Expressionsregulation sowie die subzelluläre Verteilung von CAR durch den zellulären Differenzierungsstatus beeinflusst werden kann.
The fat-soluble vitamin A, which is chemically referred to retinol (ROH), is known to be essential for the process of vision, the immune system but also for cell differentiation and proliferation. Recently, ROH itself has been reported to be involved in adipogenesis and a ROH transport protein, the retinol-binding protein 4 (RBP4), in insulin resistance and type 2 diabetes. However, there is still considerable scientific debate about this relation. With the increasing amount of studies investigating the relation of ROH in obesity and type 2 diabetes, basic research is an essential prerequisite for interpreting these results. This thesis enhances the knowledge on this relation by reviewing ROH metabolism on extra- and intracellular level. Aim 1: In the blood stream ROH is transported in a complex with RBP4 and a second protein, transthyretin (TTR), to the target cells. The levels of RBP4 and TTR are influenced by several factors but mainly by liver and kidney function. The reason for that is that liver and the kidneys are the sites of RBP4 synthesis and catabolism, respectively. Interestingly, obesity and type 2 diabetes involve disorders of the liver and the kidneys. Therefore the aim was to investigate factors that influence RBP4 and TTR levels in relation to obesity and type 2 diabetes (Part 1). Aim 2: Once arrived in the target cell ROH is bound to cellular retinol-binding protein type I (CRBP-I) and metabolised: ROH can either be stored as retinylesters or it can be oxidised to retinoic acid (RA). By acting as a transcription factor in the nucleus RA may influence processes such as adipogenesis. Therefore vitamin A has been postulated to be involved in obesity and type 2 diabetes. CRBP-I is known to mediate the storage of ROH in the liver, but the extra-hepatic metabolism and the functions of CRBP-I are not well known. This has been investigated in Part 2 of this work. Material & Methods: RBP4 and TTR levels were investigated by ELISA in serum samples of human subjects with overweight, type 2 diabetes, kidney or liver dysfunction. Molecular alterations of the RBP4 and TTR protein structure were analysed by MALDI-TOF mass spectrometry. The functions of intracellular CRBP-I were investigated in CRBP-I knock-out mice in liver and extra-hepatic tissues by measuring ROH levels as well as the levels of its storage form, the retinylesters, using reverse phase HPLC. The postprandial uptake of ROH into tissues was analysed using labelled ROH. The mRNA levels of enzymes that metabolize ROH were examined by real-time polymerase chain reaction (RCR). Results: The previous published results showing increased RBP4 levels in type 2 diabetic patients could not be confirmed in this work. However, it could be shown that during kidney dysfunction RBP4 levels are increased and that RBP4 and TTR levels are decreased during liver dysfunction. The important new finding of this work is that increased RBP4 levels in type 2 diabetic mice were increased when kidney function was decreased. Thus an increase in RBP4 levels in type 2 diabetes may be the effect of a reduced kidney function which is common in type 2 diabetes. Interestingly, during severe kidney dysfunction the molecular structure of RBP4 and TTR was altered in a specific manner which was not the case during liver diseases and type 2 diabetes. This underlines the important function of the kidneys in RBP4 metabolism. CRBP-I has been confirmed to be responsible for the ROH storage in the liver since CRBP-I knock-out mice had decreased ROH and retinylesters (the storage form of ROH) levels in the liver. Interestingly, in the adipose tissue (the second largest ROH storage tissue in the body) ROH and retinylesters levels were higher in the CRBP-I knock-out compared to the wild-type mice. It could be shown in this work that a different ROH binding protein, cellular retinol-binding protein type III, is upregulated in CRBP-I knock-out mice. Moreover enzymes were identified which mediate very efficiently ROH esterification in the adipose tissue of the knock-out mice. In the pancreas there was a higher postprandial ROH uptake in the CRBP-I knock-out compard to wild-type mice. Even under a vitamin A deficient diet the knock-out animals had ROH and retinylesters levels which were comparable to wild-type animals. These results underline the important role of ROH for insulin secretion in the pancreas. Summing up, there is evidence that RBP4 levels are more determined by kidney function than by type 2 diabetes and that specific molecular modifications occur during kidney dysfunction. The results in adipose tissue and pancreas of CRBP-I knock-out mice support the hypothesis that ROH plays an important role in glucose and lipid metabolism.